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Chapter 1. Introduction
Posttraumatic stress disorder (PTSD) is an increasingly important social and
medical issue (Kessler, 2000; Druss et al., 2009). Recent United States military
engagements around the globe, most notably Operation Iraqi Freedom and Operation
Enduring Freedom have increased the prevalence and awareness of PTSD diagnoses
attributed to exposure to military conflict in United States citizens and as a result there
has been a renewed interest in the disorder popularly and within the military and
research communities. For example, popular books and movies, both fictional and
nonfictional, have begun to utilize PTSD as major plot points and mechanisms
(Maxwell, 2011). Likewise, Governmental and military institutions have contributed
considerable money and energy towards studying PTSD. As an example, the
identification of reliable biomarkers of PTSD has been identified as a priority research
goal by the Institute of Medicine (Institute of Medicine, 2012), Department of Defense
(Congressionally Directed Medical Research Programs, 2011), and the National
Institute of Mental Health (NIMH, 2008).
Descriptions of PTSD-like syndromes can be found throughout recorded history,
including in classical Greek and Roman writings (Shay, 1994; Pitman, 2013). For
example, Plutarch describes Cassander’s response to physical and psychological
abuse from Alexander in the following way (Plutarch):
“All which made such a deep impression of terror in Cassander’s mind that, long
after, when he was King of Macedonia and master of Greece, as he was walking
up and down at Delphi, and looking at the statues, at the sight of that of
Alexander he was suddenly struck with alarm, and shood all over, his eyes rolled,
his head grew dizzy, and it was long before he recovered himself.”
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Despite these ancient accounts, we can trace the contemporary origins of the concept
of PTSD to the descriptions of post-railway accident syndromes by Charcot and
Oppenheimer in the late 1800’s (Young, 1995; Pitman, 2013). Furthermore, it wasn’t
until 1980, with the publishing of the Third Edition of the Diagnostic and Statistical
Manual of Mental Disorders that PTSD first entered official psychiatric nosology (APA,
1980).
PTSD arising out of experiences of military service largely remains the driving
force of discourse around trauma-related mental pathology, yet PTSD in the civilian
population is also highly prevalent and highly costly, both to individuals and the state. In
the United States, lifetime prevalence of PTSD is estimated to be 6.8% in the general
population (Kessler and Wang, 2008) and 15-40% in inner city and combat-veteran
populations (Villagomez et al., 1995; Breslau et al., 2004; Horowitz et al., 2005;
Schwartz et al., 2005). Additionally, PTSD is associated with numerous comorbidities,
including an increased risk of major depression (Breslau et al., 2000), substance
dependence (Breslau et al., 2003), reduced life course opportunities (Kessler, 2000),
and physical health problems (Farley and Patsalides, 2001; Simpson, 2002; Zayfert et
al., 2002) including incident cardiovascular disease (Kessler, 2000; Kubzansky et al.,
2007; Kubzansky and Koenen, 2009; Kubzansky et al., 2009). As a result, the total cost
to the nation is an estimated $3.8 billion annually (Kessler, 2000), not to mention the
incredible personal cost to individuals.
By definition, PTSD develops following exposure to a traumatic event (Shalev,
2001), witnessed or experienced by the individual; this traumatic event must involve the
threat or actuality of death, injury, or physical integrity; and must elicit a response of
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horror, fear, or helplessness (Shalev, 2001)1. Although a majority (50-90%) (Kessler et
al., 1995) of Americans experience a qualifying trauma in their lifetime, only a minority
develop diagnosable PTSD (Kessler et al., 1995; Breslau et al., 1998; Acierno et al.,
2007). It should be noted, however, that while a minority develop PTSD, a higher
percentage of individuals respond to traumatic exposures by developing an acute posttrauma syndrome that largely approximates PTSD but that resolves within a month, thus
precluding a diagnosis of PTSD (Harvey and Bryant, 1999). What accounts for
disparities in risk for PTSD is a question of intense research effort. Environmental
factors at both individual and community levels, such as gender, race, educational
attainment (Kulka RA, 1990; Brewin et al., 2000; Koenen et al., 2002; DiGrande et al.,
2008; Galea et al., 2008; Kun et al., 2009), socioeconomic position (Kulka RA, 1990;
Brewin et al., 2000; Koenen et al., 2002; Breslau et al., 2004; Koenen, 2007; DiGrande
et al., 2008; Galea et al., 2008; Kun et al., 2009), and growing up in a low-income
neighborhood (Breslau et al., 1991; Koenen, 2007) have been associated with
increased risk of PTSD. Whereas some of this increased risk may be accounted for by
individuals’ increased exposure to assaultive violence (Breslau et al., 1998; Breslau et
al., 2004; Coulton et al., 2007; Melzer-Lange et al., 2007; Reyes et al., 2008; Gillespie
et al., 2009; Obasaju et al., 2009) (the type of trauma which carries the highest
conditional risk of PTSD), biological variation may underlie observed variation in PTSD
risk. Indeed, biological factors, and their relation to PTSD (Galea et al., 2006), have

1

The diagnostic criteria detailed here is from the DSMIV-R. While completing this project, the DSM-V was
published, thus altering the diagnostic criteria. The research in this dissertation was designed using the DSM-IV
diagnostic criteria and utilized data that was collected in a manner consistent with DSM-IV diagnostic criteria. For
these reasons, DSM-IV diagnostic criteria is used throughout this dissertation.
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been given increased attention by social epidemiologists in recent years (Digangi et al.,
2013; Navarro-Mateu et al., 2013).
Recently, attempts have been made to answer the question: “How does trauma
get under the skin?” (Toyokawa et al., 2012). One putative, and increasingly empirically
supported, mechanism by which trauma can lead to biological alterations is epigenetic
variation and epigenetic modifications.

Epigenetic mechanisms and PTSD
Epigenetics refers to the stable yet modifiable regulation of gene function that
occurs through non-DNA encoded mechanisms (Feinberg, 2008). Used here, this term
refers to mechanisms that cause variation by altering the expression of genes, rather
than their sequence. Although multiple epigenetic modifications have been identified
(Kim et al., 2009), all involve chemical changes that regulate chromatin structure and/or
DNA accessibility, which in turn alters the transcriptional activity of surrounding genetic
loci. In contrast to DNA sequences, which are largely fixed, epigenetic factors are
known to change in response to individuals’ physical, biological and social exposures in
a manner that influences the long-term regulation of gene expression (Weaver et al.,
2004; Champagne et al., 2006; Bjornsson et al., 2008; Meaney, 2010). In addition to
DNA methylation (which I describe separately below), epigenetic mechanisms include
histone modifications, microRNAs, and non-coding RNAs (ncRNAs), each of which alter
the expression of DNA without changing the genetic code.
DNA methylation in particular is one of the major and best-studied epigenetic
mechanisms to date. DNA methylation occurs in vertebrates through covalent
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modification of DNA, whereby methyl groups are coupled to cytosine residues when
cytosine and guanine are separated by a phosphate (i.e., at a CpG dinucleotide site)
(Figure 1) (Bernstein et al., 2007). This chemical modification at specific DNA
sequences regulates DNA accessibility, which in turn alters the transcriptional activity of
the surrounding loci. In many cases, increased methylation in specific gene regions
(e.g. promoters) is associated with reduced transcriptional activity and, therefore, gene
expression (Eckhardt et al., 2006).

Figure 1. DNA methylation is a prominent epigenetic mechanism. DNA methylation
at the 5 position of the cytosine at a CpG dinucleotide site (right panel) affects gene
transcription via chromatin conformational changes (left panel). The left panel is
modified from Macmillan Publishers Ltd: Nature 441:143-145.
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Epigenetic factors have been the focus of increasing interest in the study of
mental illness (Ptak and Petronis, 2010), including PTSD (Yehuda, 2006; Yehuda and
LeDoux, 2007; Yehuda et al., 2009). This interest may be due to relatively few genes
having been shown to contribute to the risk of common mood-anxiety disorders (e.g.
(Lopez-Leon et al., 2008; Cornelis et al., 2010)) and evidence that epigenetic marks can
change in response to external lived experiences (Weaver et al., 2004; Weaver et al.,
2005; Champagne and Meaney, 2006; Champagne, 2009). Indeed, as regulators of
DNA accessibility and activity, epigenetic factors offer one mechanism by which the
environment can moderate the effects of genes (Rutter et al., 2006). That is, epigenetics
has the potential to collapse false dichotomies of nature vs. nurture and gene vs.
environment.
Evidence that DNA methylation is involved in the molecular pathology of mental
health disorders, including in the developing brain, has been well documented
(reviewed in (Houston et al., 2013)). As such, epigenetics offer a plausible way in which
a traumatic experience may modify gene expression such that the risk of adverse
psychopathological outcomes – PTSD for instance – increases (Yehuda et al., 2009).
Indeed, animal models of PTSD have identified epigenetic differences that can discern
rats with PTSD-like vs. non-PTSD-like behaviors (Cohen and Zohar, 2004) and, in
humans expression signatures of PTSD have been reported in individuals identified in
emergency rooms (Segman et al., 2005) or through long-term follow up of a traumatic
experience (Zieker et al., 2007). Functional analyses of differentially expressed
transcripts in these studies show a significant enrichment of genes that encode neural
and endocrine proteins; genes expressed in the amygdala, hippocampus, and in the
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HPA axis were found to be significantly overrepresented among the genes that
distinguished trauma survivors with PTSD phenotypes (Segman et al., 2005),
confirming the importance of these brain regions and biologic systems in mediating
stress reactivity. Additionally, gene expression patterns associated with PTSD have
been documented in postmortem brain tissue (Su et al., 2008) and peripheral blood
(Segman et al., 2005; Zieker et al., 2007; Yehuda et al., 2009). It is important to note
that the majority of these studies have looked at transcription changes in RNA derived
from either PBMC or whole blood. Recently, Uddin and colleagues identified
methylation-based epigenetic differences that distinguish trauma-exposed individuals
with vs. without lifetime PTSD (Uddin et al., 2010). This work was closely followed by
the publication of similar findings by Smith and colleagues (Smith et al., 2011a), with
further studies further elucidating epigenetic differences associated with PTSD risk
(Rusiecki et al., 2012; Rusiecki et al., 2013). Despite these advances, the underlying
epigenetic changes that affect downstream gene expression and PTSD development
remain largely unknown.
Elucidating epigenetic underpinnings to mental health disorders holds promise
for the development of effective treatments, as their modifiability makes them potential
targets for reversal. Studies in rats have demonstrated that pharmacological
interventions can reverse the methylation status of the glucocorticoid receptor (GR)
promoter and, consequently, the stress response, and that this reversal is possible even
in terminally differentiated tissues (Weaver et al., 2005). Results from these animal
studies render it plausible that pharmacologically modifiable epigenetic risk variants for
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PTSD may be identified in humans. Indeed, an epigenetic signature of childhood abuse
has been identified in the NR3C1 GR promoter (McGowan et al., 2009).

PTSD as adaptive trait
Whether PTSD can be understood to be an adaptive trait is a source of current
debate with biological and philosophical implications. On the one hand, PTSD is
detrimental to the mental well-being of individuals suffering from it as well as to society.
On the other hand, it is clear that in the context of an extremely dangerous environment
the complement of symptoms that constitute PTSD can be beneficial as increased
arousal and alertness, avoidance of potentially dangerous places and scenarios, and
constant reminders of passed traumatic experiences can all lead to behavioral changes
that serve to avoid or mediate future, potential traumatic experiences. This has led to
numerous perspectives on PTSD, ranging from the conclusion that PTSD is socially and
historically constructed (Young, 1995) to attempts to reduce PTSD to physical
neurobiological abnormalities (Sherin and Nemeroff, 2011). In this project, I focus my
attention not on PTSD, per se, but rather on the capacity to develop PTSD. I consider
PTSD as the product of a potentially adaptive, epigenetically regulated process of
developmental plasticity. As such, I am interested in studying this developmental
process as a biological trait. As such, if the capacity to develop PTSD is an adaptive
biological trait, then it can best be understood through the lens of Tinbergen’s “Four
Questions.”
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Figure 2. Tinbergen’s Four Questions. This figure is modified from (Springer et al.,
2011)

First proposed by Nikolaas Tinbergen, this perspective suggests that to
understand a biological trait, one must first answer four distinct, but complementary
questions concerning that trait (Figure 2):
1) What is the ontogeny?
2) What is the mechanism?
3) What is the phylogeny?
4) What is the adaptation?
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Two of these questions (1 and 2), are concerned with a proximate understanding
of the trait, while two (3 and 4) are concerned with an evolutionary understanding of the
trait. Likewise, two (1 and 3) are concerned with a trait’s history, while two (2 and 4) are
concerned with a trait’s function.
Most of the research on PTSD has attempted to answer question 2 (What is the
mechanism of PTSD?) To this end, biological correlates have been sought and
biochemical, physiological, and neuroanatomical processes have been probed to reveal
the factors that underlie PTSD risk. In contrast, much less has been done to answer the
other three questions. The first question (What is the ontogeny?), has long been a goal
of molecular epidemiologists, but has largely been precluded by the lack of large,
longitudinal human cohorts with a focus on psychiatric outcome and with access to
biological samples. The Detroit Neighborhood Health Study (DNHS), which I detail
below, is one of the first such cohorts and opens up the possibility of testing hypotheses
concerning PTSD ontogeny in human subjects. Evolutionary insights into PTSD are also
relatively few in number. The question of the functional adaptation of PTSD has been
addressed by only a few researchers directly (Silove, 1998; Bracha et al., 2005; Cantor,
2009; Horwitz AV, 2012; Anderson and Adolphs, 2014), while others have developed
theory for the potentially adaptive benefit of what is typically considered “pathological”
psychobiology (Meaney, 2010).The question of phylogeny has largely been ignored.
The work of this dissertation attempts to utilize the perspective of Tinbergen’s
Four Questions in order to identify and test hypotheses that are needed towards a more
complete understanding of PTSD.
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Outline of the dissertation
The work that follows consists of three distinct projects, which approach the
epigenetic regulation of PTSD from distinct but complementary conceptual positions.
Before describing the three projects themselves, it is necessary to describe the Detroit
Neighborhood Health Study (DNHS) and some of the related studies that have been
published to date. The DNHS is a five-wave longitudinal study. The DNHS consists of
survey and biological samples from a community-based study population of 1,547 adult
residents of Detroit, Michigan. One adult from homes included in a probability sample
within Detroit city limits (inclusive of non-phone and non-listed-households) were
recruited. Survey data includes demographics, health status, tobacco and alcohol use,
exposure to trauma, and symptoms of PTSD, depression, and anxiety. Biological
samples include peripheral blood and saliva samples. DNA and RNA was isolated from
biological samples. Demographics of the DNHS sample are similar to the greater Detroit
population in comparison to the American Community Survey (Uddin et al., 2010).
Compared with NCS-R, current (11%) and lifetime (13.9%) prevalence of PTSD in
DNHS at baseline is greater than national averages (current: 3.5%; lifetime: 6.8%
(Kessler et al., 1995)), thus creating a unique research opportunity.
The DNHS has yielded many studies, including relating to PTSD (Koenen et al.,
2011; Chang et al., 2012; Johns et al., 2012; Mitchell et al., 2013; Uddin et al., 2013;
Nevell et al., 2014), depression (Uddin et al., 2011b; Uddin et al., 2013; Nevell et al.,
2014). Most importantly for the work of this dissertation, in 2010 Uddin and colleagues
published the results of study which compared DNA methylation epigenome-wide
between trauma exposed individuals with and without PTSD (Uddin et al., 2010).
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Among the primary results of that study was a list of over 600 CpG dinucleotide sites at
which there was differential DNA methylation between PTSD and control groups. This
study raised many interesting questions. Does differential DNA methylation pre-exist
trauma exposure and PTSD development as risk and resiliency factors or do they arise
following trauma exposure and PTSD development and thus represent biomarkers?
What is the evolutionary history of the CpG sites at which the epigenetic regulation of
PTSD via differential methylation takes place? What are the relative contributions to
PTSD risk of social factors, genetic factors, and epigenetic factors? What can
epigenetics tell us about PTSD, specifically, and mental health disorders, generally?
In the dissertation that follows, I report research that was designed in order to
address several of these questions. In Chapter 2, I report research that sought to
address whether PTSD-associated differential methylation represents pre-trauma risk
factors or post-trauma biomarkers in order to shed light on Tinbergen’s Question #2:
What is the ontogeny? To do so, we took advantage of the DNHS in order to identify
thirty incident cases of PTSD. These individuals were matched on the basis of age,
gender, and trauma exposure to controls without a history of PTSD. DNA methylation
was then examined before and after trauma exposure. Among the differentially
methylated sites study by Uddin and colleagues (Uddin et al., 2010) were CpG
dinucleotides at DNMT3B and DNMT3L loci. For these reasons, we chose to examine
DNA methylation at four DNA methyltransferase genes: DNMT1, DNMT3A, DNMT3B,
and DNMT3L. The work detailed in Chapter 3 is also based on this foundational work by
Uddin and colleagues (Uddin et al., 2010). In this chapter, I report the results of a study
designed to elucidate and characterize the evolutionary history of the CpG sites at
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which Uddin and colleagues reported PTSD-associated differential methylation. By
doing so, I contribute to Tinbergen’s Question #3: What is the phylogeny? To do so, we
utilized phylogenetic methods within the context of mammals in order to infer the period
of human evolutionary descent during which various CpG sites evolved. This
evolutionary history was then biologically characterized using functional annotation
clustering and identification of transcription factor binding sites. In Chapter 4, I present
preliminary data on the association between hypothalamic-pituitary-adrenal axis SNPs
and PTSD risk, in a contribution to answering Tinbergen’s Question #1: What is the
mechanism? Finally, in Chapter 5, I attempt to bring all of these data together in order to
propose that PTSD be understood to be the product of an evolutionarily conserved,
epigenetically regulated program of developmental plasticity, thus addressing
Tinbergen’s Question #4: What is the adaptation?
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Chapter 2. Longitudinal epigenetic variation of DNA methyltransferase genes is
associated with vulnerability to post-traumatic stress disorder (PTSD)
This chapter published as:
Sipahi L, Wildman DE, Aiello AE, Koenen KC, Galea S, Abbas A, and Uddin M.
Longitudinal epigenetic variation of DNA methyltransferase genes is associated with
vulnerability to post-traumatic stress disorder. Psychological Medicine (2014) DOI:
http://dx.doi.org/10.1017/S0033291714000968.
Abstract
BACKGROUND: Epigenetic differences exist between trauma-exposed individuals with
and without posttraumatic stress disorder (PTSD). It is unclear whether these epigenetic
differences preexist, or arise following, trauma and PTSD onset.
METHODS: In pre- and post-trauma samples from a subset of Detroit Neighborhood
Health Study participants, DNA methylation (DNAm) was measured at DNMT1,
DNMT3A, DNMT3B, and DNMT3L. Pre-trauma DNAm differences and changes in
DNAm from pre- to post-trauma were assessed between and within PTSD cases (n=30)
and age-, gender-, and trauma exposure-matched controls (n=30). Pre-trauma DNAm
was tested for association with post-trauma symptom severity (PTSS) change. Potential
functional consequences of DNAm differences were explored via bioinformatic search
for putative transcription factor binding sites (TFBS).
RESULTS: DNMT1 DNAm increased following trauma in PTSD cases (p=0.001), but
not controls (p=0.067). DNMT3A and DNMT3B DNAm increased following trauma in
both cases (DNMT3A: p=0.009; DNMT3B: p<0.001) and controls (DNMT3A: p=0.002;
DNMT3B: p<0.001). In cases only, pre-trauma DNAm was lower at a DNMT3B CpG site
that overlaps with a TFBS involved in epigenetic regulation (p=0.001); lower pre-trauma
DNMT3B DNAm at this site was predictive of worsening of PTSS post-trauma
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(p=0.034). Some effects were attenuated following correction for multiple hypothesis
testing.
CONCLUSIONS: DNAm among trauma-exposed individuals shows both longitudinal
changes and preexisting epigenetic states that differentiate individuals who are resilient
vs. susceptible to PTSD. These distinctive DNAm differences within DNMT loci may
contribute to genome-wide epigenetic profiles of PTSD.

Introduction
PTSD is a prevalent and debilitating mental health disorder that may arise
following exposure to a potentially traumatic event (Association, 2013). While the
lifetime prevalence of traumatic exposure is 50-90% (Kessler et al., 1995), PTSD in the
general U.S. population is estimated to be only 6.8% (Kessler and Wang, 2008).
Although the majority of persons exposed to trauma display resiliency (Kessler et al.,
1995; Breslau et al., 1998; Acierno et al., 2007; Kessler and Wang, 2008), the molecular
underpinnings of risk remain poorly characterized. The identification of risk markers,
and particularly biomarkers, that distinguish between persons at high and low risk of
developing PTSD following trauma exposure has been identified as a priority research
goal by the Institute of Medicine (Institute of Medicine, 2012), Department of Defense
(Congressionally Directed Medical Research Programs, 2011), and the National
Institute of Mental Health (NIMH, 2008). Ideally, the ability to identify persons at high
risk of developing PTSD would enable providers to target evidence-based interventions
to high-risk groups (Andrews and Neises, 2012). The identification of robust predictive
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biomarkers may also improve our understanding of the pathophysiology of PTSD and
lead to more effective pharmacological interventions.
Although much work has been done to identify social and environmental factors
that contribute to PTSD risk [e.g. (Kulka RA, 1990; Breslau et al., 1991; Brewin et al.,
2000; Koenen et al., 2003; Breslau et al., 2004; DiGrande et al., 2008; Galea et al.,
2008; Kun et al., 2009)], the biological undergirding of differential PTSD risk and
resiliency remains to be more fully elucidated. Twin studies have demonstrated
heritability and genetic contribution to PTSD risk (True et al., 1993; Koenen et al., 2002;
Stein et al., 2002) and targeted gene and GWAS approaches have identified both
genetic risk loci (Lu et al., 2008; Ressler et al., 2011; Chang et al., 2012; Logue et al.,
2013) and important gene-by-environment interactions (Binder et al., 2008; Xie et al.,
2010; Uddin et al., 2013) that contribute to risk for the disorder; nevertheless, a
substantial proportion of biologically mediated variance in PTSD risk has yet to be
explained.
Epigenetic variability is considered a plausible and increasingly empirically
supported contributor to the etiology of phenotypes with marked genetic and
environmental

influences (Meaney,

2010), including

certain psychopathologies

(Toyokawa et al., 2012). Indeed, recent advances have revealed that PTSD risk and
resiliency is associated with differential epigenetic variation (El-Sayed et al., 2012).
Epigenetic mechanisms – including histone modifications, non-protein coding RNAs,
and, most notably, DNA methylation (DNAm) – affect gene expression and cellular
phenotype without altering the underlying DNA sequence (Feinberg, 2008; Meaney,
2010). DNAm is stably heritable across mitotic replications, but is modifiable throughout

17

the life course in response to lived experiences and environmental exposures (Bird,
2002). In primordial mammalian germ cells, global DNAm is removed (with the
exception of imprinted loci) (Reik et al., 2001), with new patterns established by de novo
methyltransferases DNMT3A, DNMT3B, and DNMT3L following fertilization (Bourc'his
et al., 2001; Bourc'his and Bestor, 2004; Kaneda et al., 2004; Kato et al., 2007; Ooi et
al., 2007). These reprogrammed DNAm patterns are largely maintained throughout
mitotic DNA replication by the action of the maintenance methyltransferase DNMT1 (Li
et al., 1992; Seisenberger et al., 2013).
Although influenced by other variables, global DNAm patterns are largely
established and maintained by the activity of the DNA methyltransferases, DNMT1,
DNMT3A, DNMT3B, and DNMT3L (Feng and Fan, 2009). Gene expression evidence
suggests that these DNMTs may be active throughout the life course (Robertson et al.,
1999; Feng et al., 2005; Siegmund et al., 2007), including in brain tissue (Goto et al.,
1994; Veldic et al., 2004; Feng et al., 2005) and in association with mental disorders
(Veldic et al., 2004; Veldic et al., 2005). In addition, protein-level expression of DNMT1
(Inano et al., 2000; Veldic et al., 2005) and DNMT3A (Feng et al., 2005) has been
demonstrated in the mouse and human brain. With respect to PTSD, recent work
confirms that DNMT activity plays a role in mediating risk for PTSD-related phenotypes,
including fear conditioning and memory consolidation (Miller and Sweatt, 2007; Feng et
al., 2010). Together, these findings suggest that DNAm and DNA methyltransferases
represent promising targets for the identification of epigenetic underpinnings of
differential PTSD risk and resiliency.
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Studies of epigenetic variation have provided important insights into PTSD risk,
but have been largely limited by cross-sectional analyses of post-trauma samples. Most
notably, epidemiological cohorts from Detroit (Uddin et al., 2010) and Atlanta (Smith et
al., 2011a) have been the basis of research that has demonstrated cross-sectional
differential DNAm that distinguishes between trauma-exposed individuals with vs.
without PTSD. DNMT3B and DNMT3L were among the differentially methylated loci
identified in the Detroit study (Uddin et al., 2010). More recently, longitudinal DNAm
data among PTSD cases and controls have been reported, including studies using
samples from a cohort of U.S. military personnel deployed to Iraq and Afghanistan
(Rusiecki et al., 2012; Rusiecki et al., 2013). To further elucidate whether differential
DNAm between trauma exposed controls and PTSD cases represent pre-existing
susceptibility/resiliency factors or downstream biomarkers of PTSD, additional
longitudinal analyses are required. Finally, while the identification of epigenetic variation
associated with mental health outcomes is important, work must begin to test the
putative functionality of mental health-associated differential DNAm. For example, the
identification of transcription factor binding sites (TFBS) that overlap with differentially
methylated CpG sites and to which transcription factor binding may be disrupted offer
one possibility of supporting DNAm functionality (Weaver et al., 2004).
Here, we analyze DNAm from individuals pre- and post-trauma to identify
differences that characterize individuals who are susceptible vs. resilient to PTSD
following trauma. To assess potential functional consequences of examined DNAm
differences, we then performed a bioinformatic search for the presence of putative
transcription factor binding sites (Weaver et al., 2004). Results from this work suggest
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that PTSD-relevant DNAm differences in DNMT loci may exist both prior to and
following trauma, with implications for future targeted interventions.

Methods and Materials
Subjects
Samples are from a subset of participants from the Detroit Neighborhood Health
Study (DNHS), a longitudinal, community-representative cohort of adult residents in
Detroit, MI. The current study draws on peripheral blood samples and survey data
obtained at two time points from 60 DNHS participants. Forty-six were female and
fourteen male; forty-six were African-American, twelve were Caucasian, and two were
Hispanic. The average age was 55.1 years. PTSD diagnosis was assessed via
structured interview administered via telephone (Breslau et al., 1998). PTSD symptoms
were assessed in reference to both the traumatic event the participant regarded as their
worst and one randomly selected traumatic event from the remaining traumas the
participant experienced. Lifetime PTSD cases met all six DSM-IV criteria in reference to
either the worst or random traumatic event. The diagnostic interview showed good
validity against the Clinician Administered PTSD Scale (Blake et al., 1995) as described
elsewhere (Uddin et al., 2010). The Institutional Review Board of the University of
Michigan reviewed and approved the study protocol. Incident cases (n=30) of PTSD
were identified in either waves 2, 3, or 4 of DNHS data collection among individuals for
whom blood samples were available at both the wave of first PTSD diagnosis and the
immediately previous, pre-incident trauma wave. Non-PTSD controls (n=30) were
matched to cases on the basis of age, sex, and number of traumatic event types. DNA
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samples were isolated from both pre- and post-trauma time points for both cases and
controls. The time between pre- and post-trauma time points was approximately 1 year.
Cases and controls had no history of PTSD prior to the post-trauma wave.

DNA Isolation:
DNA was isolated from whole blood acquired via venipuncture when available
from DNHS participants selected for inclusion in this study. Blood spots were used as
an alternate source of whole blood-derived DNA when venipuncture samples were
unavailable. The exact tissue type was shared between matched case-control pairs in
all instances. Venipuncture- and bloodspot-derived whole blood represent the same
tissue and therefore should not differ with respect to DNAm, as confirmed by numerous
studies to date (Wong et al., 2008; Aberg et al., 2013; Hollegaard et al., 2013).

Whole blood:
DNA was isolated from whole blood using the QIAamp DNA Blood Mini Kit
(Qiagen, Valencia, CA) and the QuickGene DNA Whole blood Kit S (Lifesciences,
FujiFilm, Tokyo, Japan) using manufacturers' recommended protocols.

Blood spots:
DNA was isolated using the QIAamp DNA Micro Kit (Qiagen) using the
manufacturer's recommended protocol. For each sample, one 6mm punch was taken
from dried blood spots using a disposable, sterile biopsy punch (Miltex, York, PA) within
a sterile field and placed immediately into a sterile 1.7ml microcentrifuge tube. New
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gloves, biopsy punches, and sterile fields were utilized for each sample. Negative
controls in the form of blank extractions were included with all DNA isolations.

Bisulfite conversion:
For each sample, ~750ng of DNA was bisulfite converted using the EpiTect
Bisulfite Kit (Qiagen) using the manufacturer's recommended protocol. Negative
controls in the form of bisulfite conversion of water were included with each bisulfite
conversion.

Pyrosequencing:
Assays to assess the methylation levels of CpG sites found in the DNMT1,
DNMT3A, and DNMT3L and DNMT3B (see below for assay-specific details) were
custom designed using the Pyromark Q24 Assay Design Software 2.0 (Qiagen).
Targeted CpG sites were selected based on prior evidence(Uddin et al., 2010) of
involvement in epigenetic regulation of PTSD risk (DNMT3B, DNMT3L) and to
investigate whether longitudinal, PTSD-associated DNAm differences exist across DNA
methyltransferase genes more broadly (DNMT1, DNMT3A, DNMT3B, and DNMT3L).
Because the DNMT3B target CpG is located in a CpG island, our designed assay
captures DNAm at 12 CpG sites in an approximately 70 base pair region of exon 1 (see
DNMT3B assay section below for details). Single CpG sites were assessed at DNMT1,
DNMT3A, and DNMT3L loci (see individual assay section below for details); these CpG
sites did not fall into CpG islands. DNMT1, DNMT3A, and DNMT3L CpG sites and 2
DNMT3B CpG sites assessed are also found on the HM27 and HM450K methylation
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bead chips from Illumina (see below for actual HG19 nucleotide location). The capacity
for each assay to capture DNAm levels ranging from 0-100% was validated using
commercially available demethylated and highly methylated DNA at dilutions of 1:0
(unmethylated), 3:1, 1:1, 1:3, and 0:1 (highly methylated). PCR amplification of target
sequences was performed on 20ng of bisulfite-converted DNA samples using the
PyroMark

PCR

kit

(Qiagen).

Bisulfite-converted,

PCR-amplified

DNA

was

pyrosequenced on the Pyromark Q24 Pyrosequencer (Qiagen) using the manufacturer's
recommended protocol and default settings. All methylation analyses were conducted in
triplicate with appropriate negative controls included at each of the following steps: DNA
isolation, bisulfite conversion, PCR amplification, and pyrosequencing reaction.

Details of each custom assay are listed below.
DNMT1
PCR forward primer: TTTTTTTAGGTGTGATGGGGATAAAG
PCR reverse primer (biotinylated): CAAAAACTCTCACAAACCCTTAAA
PCR program (50 cycles):
Initial 15 minutes at 95oC
Denaturation 30 seconds at 94oC
Annealing 30 seconds at 58oC
Extension 30 seconds at 72oC
Final 10 minutes at 72oC
Hold 4oC
Sequencing primer: GTGATGGGGATAAAGT
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Target

sequence:

AGCGAGAAGCCCCCAAGGGTTTGTGAGA

(CpG

target in bold; hg19: chr19:10,305,909-10,305,936)
DNMT3A
PCR forward primer: GGTGGGAGGTTGAATGAAATGA
PCR reverse primer (biotinylated): AATACCCAACCCCAAATCCTAC
PCR program (50 cycles):
Initial 15 minutes at 95oC
Denaturation 30 seconds at 94oC
Annealing 30 seconds at 58oC
Extension 30 seconds at 72oC
Final 243 10 minutes at 72oC
Hold 4oC
Sequencing primer: AGTTGGAAGATTTTGTG
Target sequence: TGTGCCTACACACCGCCCTCACCCCTTCACYGTGG
GGGCTGTTCTCCTTCCCCATGGAGYGCTCAGGGCTCTAGGTTCCTGACTTG
GGGCACCTCTGTCTAATTCCACCAGCACAGCCACTCACTATGTGCTCATCTC
ACTCCTCCAGCAGCYGCTGTAGGACTTGGGGCTGGGCACC (CpG target in
bold; hg19: chr2:25,565,782-25,565,959)
DNMT3B
PCR forward primer: GGGGTTAAGTGGTTTAAGTAAAT
PCR reverse primer (biotinylated): CCTCCAAAAATCCCTAAAAAAAATCT
CTCC
PCR program (45 cycles):
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Initial 15 minutes at 95oC
Denaturation 30 seconds at 94oC
Annealing 30 seconds at 52oC
Extension 30 seconds at 72oC
Final 10 minutes at 72oC
Hold 4oC
Sequencing primer: GTTAAGTGGTTTAAGTAAATTTAG
Target sequence: CTCGGCGATCGGCGCCGGAGATTCGCGAGCCCAG
CGCCCTGCACGGCCGCCAGCCGGCCTCCCGCCAGCCAGCCCCGACCCGC
GGCTCCGCCGCCCAGCCGCGCCCCAGCCAGCCCTGCGGCAGGTGAGCGC
CCCGGGGCCC

266

(CpG

targets

in

bold;

hg19:

chr20:31,350,382-

31,350,523)
DNMT3L
PCR forward primer: AGTTTTTTTTATTGGGGTAGTTAGG
PCR reverse primer (biotinylated): CTTAAAACCAAAAAACCACATTTTAT
TCA
PCR program (45 cycles):
Initial 15 minutes at 95oC
Denaturation 30 seconds at 94oC
Annealing 30 seconds at 50oC
Extension 30 seconds at 72oC
Final 10 minutes at 72oC
Hold 4oC
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Sequencing primer: GATTTAGGGATAGAGAGGG
Target sequence: GCGGTAGGGAGTGGGAAATCTGAATAA (CpG target
in bold; hg19: chr21:45,683,527-45,683,553)

To demonstrate the ability of our assays to resolve DNAm differences as small
as reported, we computed intraclass correlation coefficients (ICC) between triplicate
replicates for each assay. Average within-sample coefficient of variation was computed
using a two-way mixed model, using an absolute agreement definition (Shrout, 1979),
as implemented in SPSS (IBM, USA). ICCs for the 15 total CpG sites assayed ranged
from 0.703 to 0.937, with a mean ICC of 0.855 (standard deviation: 0.066). This strongly
supports the conclusion that these assays are capable of consistently resolving small
DNAm differences.

TFBS prediction
Putative TFBS were identified that overlap target CpG sites using the
MatInspector (Cartharius et al., 2005) tool from Genomatix, with default parameters.
Input sequence included 200bp up- and downstream of the CpG site. Only putative
TFBS that directly overlapped CpG sites of interest were retained.

Statistical analyses
Statistical testing was performed using SPSS Statistics for Windows, Version
21.0 (IBM Corp., USA). DNAm at DNMT3B CpG sites was treated on a regional and an
individual CpG site basis, similar to previous work (Rusiecki et al., 2013). Regional
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values were calculated as the mean of 12 CpG sites. Paired-sample t-tests were used
to test for differences in pre-trauma DNAm between cases and controls and to test for
differences between pre- and post-trauma time points within cases and controls. Linear
regression was used to test whether pre-trauma DNAm levels are predictive of post
trauma symptom severity (PTSS) changes. PTSS change was calculated as the
difference between PTSS and pre-trauma symptom severity. Analyses included severity
scores of individual symptom criteria (hyperarousal, avoidance, or intrusion symptoms)
as well as a total severity score that is inclusive of each symptom subdomain.
Regression models were adjusted for age, gender, and pre-trauma symptom severity.
The contribution of pre-trauma DNAm to post-trauma PTSS change was tested via the
change in R square values comparing full to reduced models. We present primary
results uncorrected for multiple testing as is consistent with the current state of the
science of DNAm variation in association with psychiatric endpoints (Perroud et al.,
2011; Unternaehrer et al., 2012; Perroud et al., 2013; Rusiecki et al., 2013). In addition,
to assess the extent to which our results may be attenuated by multiple hypothesis
testing correction, we calculated stringent Bonferroni-corrected significance values
(Dunn, 1961) as well as false discovery rate (FDR) Q values (Benjamini, 1995). FDR
has recently been utilized to correct multiple hypothesis testing in studies utilizing
DNAm data, with user-defined Q-values ranging from 0.05 to 0.2 (Provencal et al.,
2013; Zhao et al., 2013).
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Results
PTSD cases and controls do not differ in age, gender, ethnicity, or pre-trauma
symptom severity, including individual symptoms of intrusion, avoidance, and
hyperarousal (Table 1).

Table 1. Demographic and pre-trauma characteristics of 30 posttraumatic stress
disorder (PTSD) case-control pairs.
Controls (N = 30)
Mean/#
s.d./%
Age (years)

PTSD (N = 30)
Mean/# s.d./%

t(d.f.)

p-value

55.37

12.97

53.71

12.94

-0.47 (29)

0.638

Female

23

76.7%

23

76.7%

NA (1)

1.000

African-American

22

73.3%

24

80%

0.01 (1)

0.938

Lifetime traumas

3.80

3.83

4.43

3.70

-0.84 (29)

0.407

Assaultive Violence

0.87

1.33

1.07

1.55

-0.55 (29)

0.589

Other Injury or Shccking
Experience

0.83

1.32

1.27

1.48

-1.51 (29)

0.141

Learning about traumas to
others

1.20

1.50

1.17

1.37

0.12 (29)

0.909

Sudden Death

0.77

0.43

0.70

0.47

0.63 (29)

0.536

Other Event

0.13

0.35

0.23

0.43

-1.36 (29)

0.184

26.90

10.96

39.33

16.20

-1.12 (29)

0.275

Intrusion

9.58

7.90

11.65

6.08

-0.99 (29)

0.333

Avoidance

11.65

11.04

14.69

6.97

-1.14 (29)

0.267

Hyperarousal

8.60

7.98

11.24

5.11

-1.24 (29)

0.226

25.41

7.01

54.20

11.59

11.4 (29)

<0.001

Pre-trauma Symptom Severity

Post-trauma Symptom Severity
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Pre-trauma DNAm variation is associated with PTSD
PTSD-associated DNAm variation may both pre-exist trauma and be associated
with post-trauma PTSD outcome. To test for pre-existing protective/risk factors, pretrauma DNAm at DNMT1, DNMT3A, DNMT3B, and DNMT3L loci was compared
between trauma exposed individuals with vs. without PTSD. Pre-trauma DNAm was
higher in controls compared with cases at a single DNMT3B CpG site (CpG 9) (Figure
3; t=2.250, 29 df, p=0.032); no difference in pre-trauma DNMT3B regional DNAm mean
was observed (t=1.538, 29 df, p=0.135). We observed no pre-trauma differences
between cases and controls at DNMT1 (t=0.582, 29 df, p=335 0.565), DNMT3A
(t=0.579, 29df, p=0.567), and DNMT3L (t=1.386, 29df, p=0.176) loci.

Figure 3. Pre-trauma DNA methyltransferase 3B (DNMT3B) DNA methylation
(DNAm) is significantly higher in trauma-exposed controls compared to
posttraumatic stress disorder (PTSD) cases at CpG 9. Pre-trauma DNAm did not
differ between cases and controls at the other 11 DNMT3B CpG sites assessed. Light
gray bars indicate mean DNAm of controls. Dark gray bars indicate mean DNAm of
PTSD cases. Error bars represent standard error of the mean. Difference between
controls and cases was tested by paired-sample t-tests (N = 60; 30 cases and 30
matched controls). *: p<0.05.
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Pre-trauma DNAm variation predicts post-trauma changes in trauma symptom severity
To explore whether this PTSD-associated pre-trauma DNAm is predictive of
trauma response, we performed linear regression analyses with pre-trauma DNAm of
DNMT3B at CpG 9 and PTSS change as predictor and outcome variables, respectively.
Controlling for age, gender, and pre-trauma symptom severity, pre-trauma DNAm of
CpG 9 (Figure 4; unstandardized B=-2.318, SE=1.25 p=0.034) predicted post-trauma
symptom severity change. In this model, only pre-trauma symptom severity and pretrauma DNAm were significant predictor variables. DNMT3B CpG 9 DNAm explained
approximately 6.8% of the variance in PTS severity change, as revealed by a
comparison of the full and reduced models. The full model that included DNMT3B CpG
9 DNAm, age, gender, and pre-trauma symptom severity explained approximately 24%
of the variance in post-trauma PTSS change (Adjusted R Square=0.242, p=0.005).
Because the relationship between pre-trauma DNAm and post-trauma changes
in PTS symptom severity may be driven by distinct symptom subdomains
(hyperarousal, avoidance, and intrusion), we regressed separately each subdomain
symptom severity change onto pre-trauma DNAm, controlling for age, gender, and pretrauma symptom severity of the relevant subdomain. Pre-trauma DNAm of DNMT3B
CpG 9 (hyperarousal: p=0.249; avoidance: p=0.137; intrusion: p=0.071) did not predict
change in subdomain symptom severity.
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Figure 4. Linear regression model of symptom severity (PTSS) change posttrauma and pre-trauma DNA methyltransferase 3B (DNMT3B) CpG 9 DNA
methylation (DNAm), adjusting for age, gender, and pre-trauma symptom severity
(N=60). Only pre-trauma PTSS and DNAm were significant variables in this model.
Error bar plots represent the mean plus/minus the 95% confidence intervals.
Differences between posttraumatic stress disorder cases and trauma-exposed controls
were tested by paired-sample t- tests (N = 60; 30 PTSD cases and 30 matched
controls). *: p<0.05.
Trauma induces PTSD-associated DNAm modifications
DNAm differences may arise following trauma and be associated with PTSD
development. To test this, we compared pre-trauma DNAm with post-trauma DNAm
within PTSD cases and within trauma-exposed, healthy controls. Both PTSD-associated
and PTSD-independent changes in DNAm following trauma were observed at DNMT
loci (Figure 5). DNMT1 DNAm increased (Figure 5A; t=3.887, 29 df, p=0.001) following
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trauma in the PTSD group, but not the control group (t=1.903, 29 df, p=0.067). At
DNMT3A (Figure 5B) and DNMT3B (Figure 5C) loci, DNAm increased following trauma
in both PTSD case (DNMT3A: t=2.806, 29 df, p=0.009; DNMT3B: t=4.286, 29 df,
p<0.001) and control (DNMT3A: t=3.421, 29 df, p=0.002; DNMT3B: t=3.938, 29 df,
p<0.001) groups. No change was observed in DNMT3L (Figure 5D) DNAm in either
cases (t=1.551, 29 df, p=0.132) or controls (t=1.146, 29 df, p=0.261). Table 2 presents a
summary including uncorrected p values, Bonferroni-corrected p values, and FDR
values, as well as accompanying effect sizes, of our results described above.

Figure 5. Longitudinal DNA methylation (DNAm) modifications of DNA
methyltransferase (DNMT) loci in response to trauma in posttraumatic stress
disorder (PTSD) cases and trauma-exposed controls. DNMT3B (region) represents
the mean of 12 CpG sites. Differences between PTSD cases and trauma-exposed
controls were tested by paired-sample t-tests (N = 60; 30 PTSD cases and 30 matched
controls). Error bars represent standard error of the mean. *: p<0.05; **:p<0.01;
***:p<0.001.
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Table 2. Observed and corrected significance values of tests a
Test

Mean
Differenceb

SE

Observed
Pc

Rank

Bonferroni
threshold

FDR (BH)
thresholds

Pre- vs. post-trauma
DNMT3B in Cases

1.51

0.35

0.000*

1

0.002*

0.002*

Pre- vs. post-trauma
DNMT3B in Controls

1.51

0.38

0.000*

2

0.002*

0.003*

Pre- vs. post-trauma
DNMT1 in Cases

0.84

0.22

0.001*

3

0.002*

0.005*

3.38

0.99

0.002*

4

0.002*

0.006*

2.41

0.86

0.009*

5

0.002

0.008

0.77

0.34

0.032*

6

0.002

0.009

0.034*

7

0.002

0.011

Pre- vs. post-trauma
DNMT3A in Controls
Pre- vs. post-trauma
DNMT3A in Cases
Cases vs. Controls
DNMT3B (CpG 9) pretrauma
CpG 9 Regression analysis
(all symptoms)
Cases vs. Controls
DNMT3B (CpG 2) pretrauma
Pre- vs. post-trauma
DNMT1 in Controls
CpG 9 Regression analysis
(Intrusion symptoms)
Cases vs. Controls
DNMT3B (CpG 12) pretrauma
Cases vs. Controls
DNMT3B (CpG 10) pretrauma
Pre- vs. post-trauma
DNMT3L in Cases
Cases vs. Controls
DNMT3B pre-trauma
CpG 9 Regression analysis
(Avoidance symptoms)
Cases vs. Controls
DNMT3B (CpG 1) pretrauma
Cases vs. Controls
DNMT3B (CpG 8) pretrauma
Cases vs. Controls
DNMT3L pre-trauma

B: -2.318
0.19

0.11

0.057

8

0.002

0.013

0.56

0.30

0.067

9

0.002

0.014

0.071

10

0.002

0.016

B: -0.849
0.44

0.24

0.122

11

0.002

0.017

0.28

0.19

0.127

12

0.002

0.019

0.74

0.47

0.132

13

0.002

0.020

0.27

0.17

0.135

14

0.002

0.022

0.137

15

0.002

0.023

B: -0.821
0.35

0.23

0.151

16

0.002

0.025

0.50

0.33

0.158

17

0.002

0.027

0.91

0.65

0.176

18

0.002

0.028
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Cases vs. Controls
DNMT3B (CpG 5) pretrauma
CpG 9 Regression analysis
(Hyperarousal symptoms)

0.25

0.19

B: -0.466

0.221

19

0.002

0.030

0.249

20

0.002

0.031

Pre- vs. post-trauma
DNMT3L in Controls

0.36

0.32

0.261

21

0.002

0.033

Cases vs. Controls
DNMT3L post-trauma

0.58

0.56

0.304

22

0.002

0.034

Cases vs. Controls DNMT1
post-trauma

-0..19

0.19

0.323

23

0.002

0.036

Cases vs. Controls
DNMT3B post-trauma

0.18

0.22

0.351

24

0.002

0.038

0.56

0.66

0.356

25

0.002

0.039

0.11

0.12

0.487

26

0.002

0.041

0.09

0.20

0.565

27

0.002

0.042

-0.41

0.73

0.567

28

0.002

0.044

0.11

0.17

0.603

29

0.002

0.045

0.06

0.15

0.711

30

0.002

0.047

0.11

0.39

0.773

31

0.002

0.048

0.03

0.14

0.881
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0.002

0.050

Cases vs. Controls
DNMT3A post-trauma
Cases vs. Controls
DNMT3B (CpG 7) pretrauma
Cases vs. Controls DNMT1
pre-trauma
Cases vs. Controls
DNMT3A pre-trauma
Cases vs. Controls
DNMT3B (CpG 6) pretrauma
Cases vs. Controls
DNMT3B (CpG 3) pretrauma
Cases vs. Controls
DNMT3B (CpG 11) pretrauma
Cases vs. Controls
DNMT3B (CpG 4) pretrauma

S.E., standard error; FDR, false discovery rate; DNMT, DNA methyltransferase.
a
Corrected significance thresholds at p<0.05 are listed using two controlling
procedures: Bonferroni and FDR using the procedure of Benjamini & Hochberg
(Benjamini, 1995).
b
For regression analyses, ‘B’ represents unstandardized B values.
c
The list of observed p values is sorted from smallest to largest (indicated by rank
column).
* Values meet significance at p<0.05 for the various correction procedures.
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Transcription factor binding site prediction
DNAm is associated with gene expression. One mechanism by which increased
DNAm can lead to decreased gene expression is by affecting the binding of transactivating factors to cis-regulatory elements. To contextualize our DNAm findings, we
used bioinformatic methods to identify putative TFBS that overlap CpG sites showing
PTSD associated DNAm differences. In total, we identified 24 putative TFBS, including
2, 3, 14, and 5 that overlap DNMT1, DNMT3A, DNMT3B, and DNMT3L CpG target
sites, respectively (Table 3). Notable among these 24 TFBS are those that overlap with
CpG sites at which we identified PTSD-associated differential methylation (2 overlap the
DNMT1 CpG; 3 overlap DNMT3B CpG 9). Binding sites for heat shock factor 1 and
E2F-4/DP-2 heterodimeric complex were identified to overlap with the DNMT1 CpG site
at which an increase in DNAm was observed in PTSD cases, but not controls.
Overlapping with DNMT3B CpG site 9, at which lower pre-trauma DNAm was
associated with PTSD development and predictive of worsening of PTSS, we identified
binding sites for Human motif ten element, ZF5 POZ domain zinc finger, and the
insulator protein CTCF.
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Discussion
Our data represent preliminary findings suggesting that pre-trauma DNAm states
and post-trauma DNAm modifications differ between those who develop PTSD following
trauma and those who display resiliency. While baseline PTS symptoms did not differ
between cases and controls, baseline DNAm at a DNMT3B CpG site was higher in
resilient individuals compared to those who eventually developed PTSD. Additionally,
longitudinal change in DNAm at a DNMT1 CpG site was associated with PTSD, with an
increase in DNAm being observed in those with PTSD but not controls. Finally,
increases in DNAm were observed following trauma at DNMT3A and DNMT3B loci that
were independent of PTSD outcome, being observed in both PTSD cases and trauma
exposed controls. Although some of these results were attenuated following correction
for multiple hypothesis testing, our findings suggest that epigenetic variation plays a
complex regulatory role in PTSD risk and etiology.
One way in which DNAm may regulate gene transcription is by altering the
strength and occupancy of transcription factor binding (Weaver et al., 2004). To provide
insight into potential functional consequences of the observed PTSD-associated
differences, we conducted a secondary analysis of TFBS overlapping the distinguishing
CpG sites. Among the sites identified was a binding site for CTCF, a transcription factor
known to be involved in chromatin remodeling (Barkess and West, 2012). We identified
this binding site overlapping with DNMT3B CpG site 9, at which higher DNAm was
identified as a protective/risk factor for PTSD and symptom severity change following
trauma exposure. Differential methylation at this site is particularly compelling as a
determinant of PTSD risk, given that DNAm at CTCF binding sites has been shown to
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significantly affect CTCF occupancy (Wang et al., 2012) and downstream levels of gene
transcription (Renaud et al., 2007). Due to the nature of our samples, we are unable to
test directly whether DNAm at these identified TFBS influences gene expression. Where
available, we have utilized ENCODE data (Consortium, 2011) to provide evidence for or
against transcription factor binding at the PTSD-associated sites in blood-derived cell
types. Among the TFBS identified that overlap PTSD-associated CpG sites (DNMT1
and DNMT3B CpG 9), ENCODE data includes binding of CTCF and E2F4. ENCODE
data supports the binding of CTCF to DNMT3B in blood tissue (specifically blymphocyte cell lines: GM12864 and GM12874), but does not support the binding of
E2F4 to DNMT1. This supports the potential functionality of observed DNAm differences
at DNMT3B CpG 9 in pre-trauma samples in cases vs. controls.
DNMTs have been previously implicated in PTSD, anxiety, and fear conditioning.
In suicide completers relative to controls, DNMT3B was upregulated in the frontopolar
cortex, hypothalamus, and dorsal vagal complex and down regulated, along with
DNMT1, in

the

hippocampus

(Poulter et

al.,

2008).

Additionally,

de

novo

methyltransferases have been shown to be upregulated during contextual fear
conditioning, also in the hippocampus (Miller and Sweatt, 2007); DNMTs are required
for fear conditioning and memory consolidation as demonstrated, respectively, by
administration of DNMT inhibitors (Miller and Sweatt, 2007) and the creation of mice
with the combined knockout of DNMT1 and DNMT3A (Feng et al., 2010). Our results
thus add to the growing evidence implicating DNMTs in phenotypes of relevance to
PTSD, and of psychiatric phenotypes more broadly.
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The expression of DNMTs at the mRNA (Goto et al., 1994; Veldic et al., 2004;
Kang et al., 2011; Sterner et al., 2012) and protein (Inano et al., 2000; Feng et al., 2005;
Veldic et al., 2005) levels in post-mitotic neurons of the central nervous system
suggests that they are involved in methyltransferase activity that persists into adulthood
and that is unrelated to DNA replication (Goto et al., 1994). Indeed, previous work has
identified DNMT1 protein expression in multiple brain regions in rodents (e.g. cortex,
cerebellum (Inano et al., 2000)), as well as in specific cortical regions in adult humans
(e.g. Broadmann’s Area 9 (Veldic et al., 2005)). Furthermore, recent work suggests that
our epigenetic findings in peripheral blood may be relevant to brain tissue:
environmental exposures such as trauma have been shown to induce parallel
epigenetic modifications in peripheral blood and brain (McGowan et al., 2011; Klengel et
al., 2013). Although the current study, based on 450 living participants drawn from a
population-based cohort, precludes such work, future research is needed to address
whether the epigenetic determinants of risk observed here in peripheral blood-derived
DNA is also found in brain-derived DNA.
Importantly, this study adds to emerging work utilizing a longitudinal study design
capable of measuring biological markers prior to disease onset as well as change
between pre-disease and post-disease time points (Nieratschker et al., 2012; Rusiecki
et al., 2012; Perroud et al., 2013; Rusiecki et al., 2013). Existing longitudinal studies
have documented the importance of DNAm to mental health disorder risk, including
differential change in DNAm of BDNF among individuals with vs. without borderline
personality disorder (Perroud et al., 2013), increased DAT (SLC6A3) DNAm with age
that may be driven by alcohol dependence (Nieratschker et al., 2012), and increasing
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SERT DNAm associated with bullying (Ouellet-Morin et al., 2013). Most relevant to the
present study is work by Rusiecki et al. (Rusiecki et al., 2012) which provides evidence
for increased global DNAm in controls, but not cases following trauma exposure,
suggesting that resiliency is associated with increased global DNAm, potentially
mediated by increased activity and expression of DNMTs. Indeed, our data presented
here is consistent with this scenario, as DNAm of DNMT1 was observed to increase
following trauma in cases, but not controls. In contrast, however, we observed an
increase in DNMT3B DNAm following trauma in both cases and controls, and a pretrauma association between higher DNAm pre-trauma and resiliency post-trauma. The
presence of a CTCF binding site opens the possibility that increased DNAm at this locus
is associated with increased gene expression 473 because CTCF can act as either a
transcriptional activator or repressor (Phillips and Corces, 2009), with strength of DNA
binding inversely correlated with local DNAm (Barkess and West, 2012). If binding of
CTCF to the DNMT3B locus results in transcriptional repression, then increased DNAm,
and concurrent decreased CTCF binding, would be associated with increased, not
decreased, gene expression. If true, this would put these findings in line with the
previously published, longitudinal, trauma-associated epigenetic data: decreased DNAm
in pre-trauma PTSD cases would result in tighter CTCF binding and reduced DNMT3B
transcription and lower global DNAm levels, as reported by Ruisecki and colleagues
(Rusiecki et al., 2012). Although DNMT1 is typically thought to maintain DNAm in adult
tissues, evidence suggests that DNMT1 and DNMT3B cooperatively maintain DNAm,
with one or the other, but not both, required for global DNAm (Rhee et al., 2002). More
broadly, our data adds to the emerging evidence that longitudinal DNAm changes may
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contribute to the etiology of mental illness and can be taken as a proof of principle that
locus-specific epigenetic variability both pre-exist and arise following disease-onset in
biologically meaningful ways.
While our study is one of the first of its kind to compare pre- and post-trauma
DNAm levels with regard to the development of PTSD, there is a minimum of four study
limitations that should be kept in mind when interpreting our results. First, it is important
to recognize that the epidemiological nature of our cohort precludes sample collection
with a well-controlled experimental time course; times between pre-trauma data
collection, trauma exposure, and post-trauma data collection differed between each test
subject. As such, we are unable to resolve whether observed PTSD-associated posttrauma DNAm changes precede PTSD-development (i.e. occurred within the first four
weeks following trauma). As DNMTs are involved in the global regulation of DNAm, it is
tempting to conclude from our data that observed changes in DNMT DNAm are an
upstream process of PTSD development, thereby having the potential to help explain
differences in DNAm epigenome-wide reported elsewhere (Uddin et al., 2010; Smith et
al., 2011a; Rusiecki et al., 2012). However, it is also possible that the observed PTSD
associated DNAm changes are downstream effects of PTSD development, with no or
little involvement in epigenetic modifications across the epigenome. Second, the nature
of the epidemiological samples collected precluded the assessment of pre- and posttrauma gene expression differences and changes, as well as any analysis of blood cell
composition. Third, the DNAm differences and effect sizes reported here are small;
however, they are consistent with published work showing functional effects of DNAm
variation (Tyrka et al., 2012). High intraclass correlation coefficients between
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experimental replicates for each of our assays increases confidence of the validity of
observed DNAm differences. Indeed, our sample size and observed effect sizes are
consistent with published work in the field (Perroud et al., 2011; Byrne et al., 2013).
Fourth, our results are not corrected for multiple testing. Although this is consistent with
the current state of the science of DNAm variation in association with psychiatric
endpoints (Perroud et al., 2011; Unternaehrer et al., 2012; Perroud et al., 2013;
Rusiecki et al., 2013), we do report corrected results (Table 2) to assess the degree to
which our findings might be attenuated by multiple hypothesis test correction. Accepting
a stringent FDR of 0.05 requires that we reject several findings reported as significant in
our study, notably pre-trauma DNAm differences between cases and controls at
DNMT3B CpG 9. However, it also means that a significant association between DNAm
and PTSD emerges as a result of correction, as a significant change in DNAm at
DNMT3A following trauma is only seen in controls at this stringent FDR cutoff and
would therefore be suggestive of a resiliency-associated change in DNAm (Table 2).
While we have chosen to utilize a stringent FDR cut-off of 0.05, other DNAm analyses
have accepted a cut-off as high as 0.20 (Provencal et al., 2013). Overall, we stress the
preliminary nature of these findings—both uncorrected and corrected for multiple
hypothesis testing—and the importance of replication in an independent cohort.
Individuals exposed to trauma differ in their risk for subsequent PTSD. Our data
suggest that variation in pre-trauma DNAm and post-trauma DNAm change may be part
of the molecular underpinnings of PTSD risk and resiliency. Future research is needed
to determine if the DNAm variation observed here is associated with functional changes
that affect the long-term biology of individuals exposed to trauma. The identification of
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risk markers, including epigenetic markers, is an important step to understanding the
biological underpinnings of PTSD risk and may lead to the development of tools to
identify those individuals most at risk of developing PTSD as well as to develop
evidence-based interventions.
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Chapter 3. Ancient evolutionary origins of epigenetic regulation associated with
posttraumatic stress disorder
This chapter published as:
Sipahi L, Uddin M, Hou Z, Aiello AE, Koenen KC, Galea S, and Wildman DE (2014)
Ancient evolutionary origins of epigenetic regulation associated with posttraumatic
stress disorder. Front. Hum. Neurosci. 8:284. doi: 10.3389/fnhum.2014.00284.
Abstract
Epigenetic marks, including DNA methylation, are modifiable molecular factors
that may underlie mental disorders, especially responses to trauma, including the
development of and resilience to posttraumatic stress disorder (PTSD). Previous work
has identified differential DNA methylation at CpG dinucleotide sites genomewide
between trauma exposed individuals with and without PTSD, suggesting a role for
epigenetic potential – the capacity to epigenetically regulate behavior and physiology in
response to lived experiences. The human species is characterized by an increased
period of adaptive plasticity during brain development. The evolutionary history of
epigenetic potential in relation to adaptive plasticity is currently unknown. Using
phylogenetic methods and functional annotation analyses, we trace the evolution of
over 7,000 CpG dinucleotides, including 203 associated with PTSD, during the descent
of humans in during mammalian evolution and characterize the biological significance of
this evolution. We demonstrate that few (7%) PTSD-associated CpG sites are unique to
humans, while the vast majority of sites have deep evolutionary origins: 73% and 93%
were unambiguously present in the last common ancestor of humans/orangutans and
humans/chimpanzees, respectively. Genes proximal to evolved PTSD-associated CpG
sites revealed significant enrichment for immune function during recent human evolution
and regulation of gene expression during more ancient periods of human evolution.
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Additionally, 765 putative transcription factor binding motifs (TFBMs) were identified that
overlap with PTSD-associated CpG sites. Elucidation of the evolutionary history of
PTSD-associated CpG sites may provide insights into the function and origin of
epigenetic potential in trauma responses, generally, and PTSD, specifically. The human
capacity to respond to trauma with stable physiologic and behavioral changes may be
due to epigenetic potentials that are shared among many mammalian species.

Introduction
The human species is characterized by an increased period of adaptive plasticity
during brain development (Chugani, 1998; Sterner et al., 2012). This phenotypic
plasticity enables individuals to respond in unique ways to environmental stimuli. Among
other mechanisms, DNA methylation regulates phenotypic plasticity through epigenetic
marks that are stable yet capable of experience-mediated dynamic change (Moore et
al., 2013). Although DNA methylation may underlie mechanisms of phenotypic plasticity,
the functional evolution of DNA methylation-mediated plasticity requires the presence of
a genetic nucleotide substrate – the CpG dinucleotide. We thus refer to the presence of
CpG dinucleotides required for phenotypic plasticity, “epigenetic potential”. The
evolutionary history of this epigenetic potential is crucial to understanding various forms
of phenotypic plasticity and related mental health outcomes.
Posttraumatic stress disorder (PTSD) and resiliency comprise two phenotypes
that may arise subsequent to exposure to a traumatic event. Given that trauma is
unpredictable yet probable within a lifetime, mechanisms of phenotypic plasticity in
response to trauma are expected to exist, despite the prediction that such mechanisms
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will be costly (West-Eberhard, 2003). As such, we expect the epigenetic potential that
underlies the capacity for trauma-induced phenotypic plasticity is possibly highly
conserved. In humans, PTSD and trauma resiliency are associated with differential DNA
methylation genomewide (Uddin et al., 2010; Smith et al., 2011b) and, therefore, may
be regulated by epigenetic potential.
Diagnostically, PTSD is a mental health disorder characterized by symptoms of
intrusion, avoidance, and alterations in cognition and mood that cause distress or social
impairment, last for more than one month, and are associated with a traumatic event
consisting of direct or indirect exposure to actual or threatened death, injury, or sexual
violation (Association, 2013). Although PTSD diagnoses have historically been confined
to humans, the capacity to express traumatic symptoms likely exists on other primate,
and possibly non-primate mammalian, lineages. For example, abused chimpanzees
have been reported to exhibit symptoms that in humans are considered characteristic of
PTSD, including symptoms of avoidance, arousal, and dissociation (Bradshaw et al.,
2008; Ferdowsian et al., 2011); elephants exposed to human violence have been
documented exhibiting behaviors characterized by hyperaggression, abnormal startle
response, depression, and asocial behaviors (Bradshaw et al., 2005); and rodents have
been used as a model of PTSD, given their responses to trauma of social withdrawal
and hyperarousal (Siegmund and Wotjak, 2006). These observations suggest that the
capacity to express traumatic symptoms in response to extreme stress exists on nonhuman lineages within primate or mammalian clades and that this capacity may be an
ancestral state (Horwitz AV, 2012).
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Emerging evidence suggests that epigenetic variation may help explain observed
differential susceptibility and resilience to PTSD in humans (Breslau et al., 1998).
Indeed, recent studies (Uddin et al., 2010; Smith et al., 2011b; Mehta et al., 2013), have
demonstrated differential DNA methylation genomewide between individuals with PTSD
and trauma exposed individuals without PTSD. Each of these studies demonstrated
epigenetic dysregulation of immune system genes (Uddin et al., 2010; Smith et al.,
2011b) – a finding that is consistent with the knowledge that the hypothalamic-pituitaryadrenal axis modulates the immune system (Wong, 2002; Irwin and Cole, 2011) and
findings from previous publications that differential gene expression patterns in genes
involved in immune activation exist between PTSD-affected and -unaffected individuals
(Segman et al., 2005; Zieker et al., 2007). PTSD, therefore, appears to be epigenetically
regulated.
The evolutionary history of human epigenetic potential in relation to traumainduced phenotypic plasticity would likely be informative of human phenotypic plasticity
responses, generally, and PTSD, specifically. We hypothesized that the capacity to
regulate behavioral, physiological, and psychological processes in response to
traumatic experiences is mediated by epigenetic regulation at genetically inherited CpG
loci that are largely conserved across mammalian species. Specifically, we expect that
most of the CpG sites associated with the epigenetic regulation of PTSD will be largely
conserved (that is, not unique to humans), but instead will have much more ancient
origins. Here we test this hypothesis by tracing and characterizing the evolution of
human CpG dinucleotides previously associated with DNA methylation patterns in
whole blood that differentiate trauma exposed individuals with PTSD from those without
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PTSD. Doing so, we reveal the phylogenetic history of genetic CpG sites previously
shown to be associated with the capacity to epigenetically regulate PTSD in humans
and characterize different periods of the evolution of humans and other mammals.

Materials and Methods
Emergence of CpG Sites during Human Descent
Human

CpG

site

annotation

data

was

obtained

from

the

Infinium

HumanMethylation27 (HM27) DNA Analysis BeadChip by Illumina, which targets 27,578
CpG sites in more than fourteen-thousand genes. Multiple sequence alignments were
constructed using both Ensembl (v54, PECAN(Paten et al., 2008) for global multiple
sequence alignments) and UCSC (Feb. 2009 assembly; Z-blast (Rosenbloom et al.,
2010) for local multiple sequence alignments) using publicly available genomes of the
following species: human (Homo sapiens), chimpanzee (Pan troglodytes), orangutan
(Pongo abelii), macaque (Macaca mulatta), mouse (Mus musculus), rat (Rattus
norvegicus), cow (Bos taurus), horse (Equus caballus), dog (Canis lupus familiaris),
opossum (Monodelphis domestica), platypus (Ornithorhynchus anatinus), and chicken
(Gallus gallus). The accelerated transformation maximum parsimony (ACCTRAN)
algorithm (JS, 1970), implemented in PAUP*4.0, was used to infer ancestral CpG site
statuses for 19,711 alignable CpG sites. Only CpG sites for which alignments could be
constructed using both UCSC and Ensembl and for which ancestral states were inferred
unambiguously by parsimony (CI=1) were utilized in downstream analyses. Using this
process, the evolutionary history of 7202 CpG sites were unambiguously inferred along
human descent within the context of a 12 species mammalian phylogenetic tree.
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A note on human descent branch labels
Throughout this paper we refer to branches on human descent in the following
way, with divergence times estimates from (Meredith et al., 2011) where applicable, and
(Jameson et al., 2011) for primate nodes.
Human terminal: 7.2 million year period from the LCA of humans and
chimpanzees until present.
Human/chimpanzee stem: 10.8 million year period from the LCA of humans and
orangutans (18.0mya) to the LCA of humans and chimpanzees (7.2mya).
Ape stem: 7.4 million year period from the LCA of humans and macaques
(24.5mya) to the LCA of humans and orangutans (18.0mya).
Primate stem: 57.9 million year period from the LCA of humans and rodents
(83.3mya; here represented by rat and mouse) to the LCA of humans and
macaques (25.4mya).
Euarchontoglires stem: 8.7 million year period from the LCA of humans and
Laurasiatherians (92.0mya; here represented by dog, horse, and cow) to the
LCA of humans and rodents (83.3mya).
Placental stem: 98.0 million year period from the LCA of humans and
opposums (190.0mya) to the LCA of humans and Laurasiatherians (92.0mya).
Theria stem: 27.8 million year period from the LCA of humans and platypus
(217.8mya) to the LCA of humans and opossum (190.0mya).
Mammal stem: 106.7 million year period from the LCA of humans and chickens
(324.5mya) to the LCA of humans and platypus (217.8mya).
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Evolution of PTSD-associated CpG sites during Human Descent
To gain insights into the evolutionary history and functional adaptive nature of
PTSD, we inferred the evolutionary history of 203 PTSD-associated CpG sites identified
by Uddin et al (Uddin et al., 2010). Smith et al. (Smith et al., 2011b) and Mehta et al.
((Mehta et al., 2013)) have also published associations between PTSD and differential
DNA methylation. Because samples utilized by these studies were chosen based on
substantially different selection criteria – confined to PTSD in Uddin et al (Uddin et al.,
2010), whereas including selection for total life stress and childhood abuse in Smith et
al. (Smith et al., 2011a) as well as Mehta et al. (Mehta et al., 2013) – we have chosen to
analyze here only those PTSD-associated CpG sites identified by Uddin et al (Uddin et
al., 2010).
The following was completed on the 203 PTSD-associated CpG sites from Uddin
and colleagues (Uddin et al., 2010) that mapped unambiguously onto our 12 species
phylogenetic tree. Branch-specific rates of evolution during human descent were
calculated using divergence dates estimates detailed above. Chi-square tests were
utilized to analyze branch specific rates of evolution and are described in following:
1) a Chi-square test was used to test whether statistically significant
differences exist between the branch distribution observed in the whole
dataset (7202 sites) and the PTSD-associated subset (203 sites). For this
test, expected and observed values represent, respectively, the
distribution of changes of the whole data set and the PTSD-associated
dataset.
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2: a Chi-square test was used to test whether the number of PTSDassociated changes was branch specific (all branches considered).
Respectively, expected and observed values represent an even
distribution of changes and the actual distribution of changes in the
dataset.
3: given that there was a statistically significant difference according to
branch, we used Chi-square tests to determine which branches differed
from one-another (all individual branches compared to all other individual
branches).
Putative transcription factor binding motifs (TFBMs) were identified that overlap
with CpG sites of interest using the Genomatix MatInspector (Quandt et al., 1995;
Cartharius et al., 2005) tool, with default settings. Input sequences included 60 base
pairs up- and downstream of PTSD-associated CpG dinucleotide sites, as obtained
from the Infinium HumanMethylation27 (HM27) DNA Analysis BeadChip by Illumina.
The Database for Annotation, Visualization and Integrated Discovery (DAVID) (Huang
da et al., 2009) was used with default settings to assess branch-specific enrichment of
gene ontology terms and functional annotation clustering (FAC) among genes proximal
to PTSD-associated CpG sites. Genes proximal to the 7202 total CpG sites for which
evolution was unambiguously inferred were used as background for enrichment
computations. Functional annotation clusters with Enrichment Scores greater than 1.3
were considered significant (Cartharius et al., 2005; Huang da et al., 2009).

51

Results
Inference of PTSD-associated CpG dinucleotide phylogenetic history
The phylogenetic histories of 7202 CpG dinucleotide sites from across the
genome and assessed by the DNA methylation microarray were unambiguously
mapped onto a mammalian phylogenetic tree (Figure 6A) by inferring ancestral states
using a maximum parsimony method (Supplemental Table 1). Of these, 203 were
previously identified to be differentially methylated in association with PTSD (Uddin et
al., 2010).
Of the 7202 human CpG sites examined in extant mammals, 10.5%, 52.0%, 75.0%, and
91.4% were present in the last common ancestor (LCA) of humans and rodents, Old
World monkeys, orangutans, and chimpanzees, respectively. 8.6% of the CpG sites
assessed evolved on the human terminal branch. The percentage of of 203 PTSDassociated CpG sites evolved prior to the LCA of humans and rodents (7%), Old World
monkeys (48%), orangutans (73%), and chimpanzees (93%) showed a branch
distribution that did not differ statistically from that observed among the total 7202
assessed CpG sites (chi-square=0.044, df=7, p>0.99) (Figure 6B). Among all CpG sites
assessed as well as the subset of those associated with PTSD, there was a statistically
significant association between branch of human descent and number of evolved CpG
sites (Table 1; Total: chi-square=7936.26, df=7, p<0.0001; PTSD subset: chisquare=247.56 df=7, p<0.0001), such that the number of evolved PTSD-associated
CpG sites was lowest on the mammal, Theria, placental, and Euarchontoglires stems,
rose sharply beginning with the primate stem, peaked on the ape stem, and then
decreased slightly on the human/chimpanzee stem and human terminal branch. The
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number of PTSD-associated CpG sites that evolved on the primate stem was
significantly greater than any other branch of human descent assessed. (Table 1, Figure
6B).

Figure 6. Evolutionary history of PTSD-associated CpG dinucleotides. Bars, tree
branches, and time scales in panels A-C are color coordinated and vertically aligned.
Red: mammal stem; Orange: Theria stem; Yellow: placental stem; Green:
Euarchontoglires stem; Light Blue: primate stem; Dark Blue: ape stem; Purple:
human/chimpanzee stem; Pink: human stem A) Mammalian phylogenetic tree with
species genomes utilized for the inference of molecular evolution here. Divergence
dates at internal nodes along human descent, in millions of years ago. B) The absolute
number (colored bars) and cumulative percentage (gray bars) of PTSD-associated CpG
sites evolved on branches of human descent, as inferred by parsimony. C) Branchspecific rates of evolution of PTSD-associated CpG sites through human descent.
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Because there is high variability among the evolutionary time that spanned each
of the branches assessed (Figure 6A), we computed branch-specific rates of evolution
of total and PTSD-associated CpG sites (Figure 6C). The evolutionary rate of PTSDassociated CpG sites was statistically greater on the primate, ape, human/chimpanzee,
and human terminal branches compared to that on the mammal, Theria, placental, and
Euarchontoglires branches (Table 1, Figure 6C). PTSD-associated CpG sites evolved at
the highest rate (6.9 changes/million years) on the ape stem (Table 1, p<0.001 vs. all
other branches). The rate of PTSD-associated CpG site evolution was lowest (Table 1)
during human descent from the last common ancestor of all extant mammals 324.5
million years ago until the LCA of humans and rodents 92 million years ago (combined
mammal+Theria+placental+Euarchontoglires stem lineages), during which time the
evolutionary rate of PTSD-associated CpG sites never exceeded 0.2 changes/million
years; the rate of PTSD-associated CpG evolution did not significantly vary between
these branches of more ancient human descent (Table 1). Additionally, we observed a
strong association between branch-specific evolution of all CpG sites and PTSDassociated CpG sites (Figure 7; R2=0.98338). That is, the proportion of PTSDassociated CpGs among all evolved CpGs was found to scale linearly through human
descent.
Gene functional enrichment analyses of PTSD-associated CpG dinucleotides
In order to shed light on selection pressures and biological significance of the
evolution of PTSD-associated CpG sites, we tested for enrichment of gene ontology
terms among genes located proximal (as predicted by beadchip annotation) to evolved
PTSD-associated CpG sites. Background for this enrichment analysis was genes
proximally located to the 7202 total CpG sites for which evolutionary history was
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unambiguously inferred (Supplemental Table 1). Enrichment analyses were completed
for all 203 PTSD-associated CpG sites identified by Uddin et al (Uddin et al., 2010)
(Supplemental Tables 2, 3, and 4) as well as on a branch-by-branch basis (Table 2).
Annotation clusters with the five highest enrichment scores on each branch are listed in
Table 2. The complete results of functional annotation analyses, including enriched GO
terms (Supplemental Table 2) and significantly enriched Functional Annotation Clusters
(Supplemental Table 3) can be found in Supplemental Tables; Significant FAC results
(considered here to be those clusters with enrichment scores greater than 1.3 (Huang
da et al., 2009)) can be found in Supplemental Table 4. We detail several noteworthy
findings below.

Figure 7. Proportion of PTSD-associated CpG dinucleotides among all evolved
CpG dinucleotides scales linearly through human descent. Color of circles
corresponds to branches of human descent, as indicated in Figure 6. Red: Mammal
stem; Orange: Theria stem; Yellow: placental stem; Green: Euarchontoglires stem; Light
Blue: primate stem; Dark Blue: ape stem; Purple: human/chimpanzee stem; Pink:
human stem.
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In general, enriched annotation clusters involved transcriptional regulation
throughout human descent, with the addition of immune-related annotations during
more recent periods of human descent (Table 2). The human/chimpanzee stem lineage,
during which the rate of PTSD-associated CpG evolution was greatest, was significantly
enriched in annotation clusters involved in immune function, including adaptive (b cell
receptor signaling pathway) and innate immune response (natural killer cell-mediated
cytotoxicity) (Table 2). Likewise, the human terminal and ape stem lineages were
enriched for immune response and B cell signaling annotation clusters, respectively
(Table 2). Previous studies have found differential expression of immune function genes
between trauma exposed persons with and without PTSD (Segman et al., 2005; Zieker
et al., 2007). It is noteworthy, therefore, that the human terminal branch showed a FAC
enriched for a number of immune functions including among others: immune response,
immune response-activating cell surface receptor signaling pathway, T cell activation,
lymphocyte activation, and leukocyte activation (Table 2).
In contrast, the primate stem lineage, on which the greatest number of PTSDassociated CpG sites evolved, had a FAC heavily associated with transcriptional
regulation, including genes involved in epigenetic regulation: HDAC1 and HDAC11
(Table 2). Additionally, the annoation clusters with the three highest enrichment scores
were found on the primate stem; each involved in transcriptional regulation and heavily
enriched for zinc finger transcription factors (Table 2). It is noteworthy also that, with the
exception of the human terminal, human/chimpanzee branch, and Euarchontoglires
branch, each branch contained among its five most enriched clusters at least one
involved in transcriptional regulation (Table 2).
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Table 5. Top 5 functional annotation clusters of genes proximal to PTSDassociated CpG sites evolved on different branches of human descent.
Stem Branch

Annotation Cluster

Cluster Rank

Enrichment Score

Human

Plasma membrane

1, 2, 3, 4

Immune Response

5

3.30, 2.98, 1.47,
1.45
1.30

Pathways in cancer

1

3.20

B cell receptor signaling pathway

2

3.17

MAPK/GnRH/Fc epsilon RI
signaling
Intestinal immune network (IgA)

3, 4

2.85, 2.38

5

2.09

zinc finger/ion binding

1

3.75

Plasma membrane

2

3.51

Transcription/Zinc finger regions

3

3.29

B cell/Fc epsilon RI/VEGF/GnRH/
Natural killer cell Signaling

4

2.68

Long-term potentiation

5

2.46

zinc finger region:C2H2

1, 2

7.74, 4.09

Transcription regulation

3

4.01

Plasma membrane

4

3.52

Intracellular organelle lumen

5

3.24

Euarchontoglires

Src homology-3 domain

1

1.32

Placental

transcription regulation

1, 2

2.88, 2.13

Protein modification

3

1.84

Cell fraction

4

1.35

Regulation of apoptosis

5

1.31

intracellular, non-membrane
bound

1

2.80

Transcription regulation

2

2.39

DNA-binding/helix-loop-helix

3

1.98

Organelle lumen

4

1.94

Sensory perception

5

1.42

negative regulation of
transcription

1

1.71

Human/chimpanzee

Ape

Primate

Theria

Mammal
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Transcription factor binding motif identification and characterization
As DNA methylation can regulate gene expression by structurally blocking
transcription factor binding within gene promoter regions(Curradi et al., 2002), we
sought to identify putative transcription factor binding sites that overlap with the 203
PTSD-associated CpG sites. Using a motif prediction algorithm, 765 total transcription
factor binding motifs (TFBMs) were identified that overlap 196 PTSD-associated CpG
sites. Of these, 765, 407, 188, and 22 putative TFBMs were identified that overlap with
196, 163, 107, and 21 unique PTSD-associated CpG sites at detection stringencies
(mat_sim) of >0.80, >0.90, >0.95, and =1, respectively (Supplemental Table 5). A
stringency score of 1 indicates that the candidate sequence corresponds to the most
conserved nucleotide at each position of the reference matrix. The 22 TFBMs with the
highest stringency score (i.e. 1) spanned 21 different PTSD-associated CpG sites
(Table 3). Two TFBMs with a stringency score of 1 spanned the CpG site cg13316424
of the gene CIZ1. Further, these 22 TFBMs were distributed among 9 different matrix
families (Table 3). Notably, 4 of these TFBMs represent binding sites for transcription
factor II B, which makes up the RNA polymerase II pre-initiation complex, while 2 are
putative bindings sites of the transcription factor Beta2/NeuroD, which is responsible for
neuron- and endocrine cell-specific gene expression. PTSD-associated CpG sites that
overlap the RNA polymerase II pre-initiation complex binding motifs evolved on the ape
(cg10498097/MGC50811), primate (cg04033774/GPSM2 and cg20318748/NANP), and
placental (cg24673765/HSPB6) stem lineages, while those that overlap with
Beta2/NeuroD binding motifs evolved on the ape (cg04587829/FN3K) and primate
(cg00427635/TBC1D21) stem lineages. The branch-specific breakdown of the evolution
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of the 22 high stringency TFBMs is as follows: human (2), human/chimpanzee (5), ape
(6), primate (5), placental (2), and therian (2).

Table 6. Matrix Families of TFBMs (mat_sim=1) that overlap PTSD-associated CpG
dinucleotides.
Matrix Family

CpG

Gene

Stem Branch

C2H2 zinc finger transcription factors 2

cg27318281 C18ORF37

Human

cg19047670 CCND1

Human/chimpanzee

cg00962459 PROKR1

Ape

cg03570766 CATSPER1 Ape
cg12439773 SLC22A6

Theria

cg10498097 MGC50811

Ape

cg04033774 GPSM2

Primate

cg20318748 NANP

Primate

cg24673765 HSPB6

Placental

cg06445611 GABRR2

Human/chimpanzee

cg24505375 AMAC1L2

Human/chimpanzee

cg13316424 CIZ1

Primate

cg21835643 RBPSUHL

Theria

cg04587829 FN3K

Ape

cg00427635 TBC1D21

Primate

cg19531130 ANGPTL5

Human/chimpanzee

cg01813965 C16orf50

Ape

Cart-1 (cartilage homeoprotein 1)

cg13316424 CIZ1

Primate

Human and murine ETS1 factors

cg06084117 PLXNA4B

Human/chimpanzee

cg20792833 PTPRCAP

Placental

Vertebrate SNAD family of transcription
factors

cg13471990 ENTPD1

Ape

Par/bZIP family

cg25293251 GOLGA5

Human

RNA Polymerase II transcription factor II B

Pleomorphic adenoma gene

NeuroD, Beta2, HLH domain
TALE homeodomain class recognizingTG
motifs
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Discussion
Epigenetic modifications provide a mechanism by which lived experiences can
reprogram gene expression patterns and affect biological processes broadly. The
epigenetic potential to respond to stress and trauma is likely conserved across
mammalian species. As such, we predicted that the genetic elements (CpG dinucleotide
sites) required for this epigenetic potential would be conserved. We have previously
demonstrated that differential DNA methylation of CpG dinucleotides genomewide
distinguish those with PTSD from trauma exposed individuals without PTSD (Uddin et
al., 2010). Here, by tracing and characterizing the evolutionary history of 203 of these
PTSD-associated CpG dinucleotide sites using functional annotation clustering and
transcription factor binding motif identification, we provide evidence that the genetic
substrate associated with divergent epigenetic responses to trauma is largely conserved
across mammalian species. Among those PTSD-associated CpG sites for which we
could unambiguously infer ancestral states, we demonstrate that 1) the majority evolved
prior to the LCA of humans and Old World monkeys, 2) there is an enrichment among
genes found proximal to evolved PTSD-associated CpG dinucleotides on all branches
of human descent for annotation clusters involved in transcriptional regulation, while
more recent branches of human descent (ape and human/chimpanzee stem branches,
and human terminal branch) are enriched also for immune function-related annotation
clusters; and 3) there is overlap with more than 800 putative TFBMs, the 22 most
stringently selected of which fall into 9 TFBM families and evolved overwhelmingly on
primate, ape, human/chimpanzee, and human stem terminal. Taken together, our data
demonstrate that the human potential to epigenetically regulate traumatic responses
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may be shared with non-human primates and that the evolution of this capacity likely
involved the targeting of TFBMs of many genes, including those involved in immune
response and transcriptional regulation.
Functional annotation clustering and enrichment analysis of gene ontology terms
identified enrichment of FACs involved in immune functioning that emerged throughout
human descent generally, with over representation primarily concentrated during the
most recent 15 million years of human evolution. It is notable that immune function
dysregulation is a common finding among individuals with PTSD (Uddin et al., 2010;
Smith et al., 2011b) and evidence suggests that the immune system may play an
important role in PTSD phenomenology (Segman et al., 2005; Zieker et al., 2007).
Although not surprising, it is important to note that functional annotation enrichment
among the 203 PTSD-associated sites tested here do not markedly differ from that
observed in the larger dataset of 624 differentially methylated sites from Uddin and
colleagues (Uddin et al., 2010). Indeed, the immune system interfaces closely with the
HPA axis, a key regulator of the stress response. Glucocorticoids from the HPA axis
trigger changes in expression of cytokines and inflammatory genes in leukocytes, while
cytokine receptors in the hypothalamus trigger the release of glucocorticoids from the
HPA axis in response to immune activation (Irwin and Cole, 2011). This complex
interplay between the HPA axis and the immune system supports the evidence of
immune involvement presented here. The identification of enriched immune function
FACs may suggest recent evolutionary innovations or selection pressures on the ability
of the immune system to respond to environmental exposures, possibly including
trauma. Moreover, there is now clear evidence that the immune response is associated
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with a variety of mood disorders, and that cytokine activation in peripheral blood as well
as brain cells, particularly microglia, underlie this association (Jones and Thomsen,
2013).
DNA methylation is thought to regulate gene expression, in part, by blocking the
binding of transcription factor to binding sites (Iguchi-Ariga and Schaffner, 1989).
Indeed, while several studies have identified differential methylation between trauma
exposed individuals affected and unaffected by PTSD (Uddin et al., 2010; Smith et al.,
2011b), it is unclear what functional connection explains this association. Here, we
identified approximately 800 putative transcription factor binding motifs that overlap
PTSD-associated CpG sites, 22 of which met the highest detection stringency.
Interestingly, 13 of these 22 putative binding sites overlapped with PTSD-associated
CpG sites that evolved during relatively recent human evolution (human terminal = 2,
human/chimpanzee stem = 5, ape stem = 6).
Our approach is novel in that it combines empirical insights of epigenetic
variation to inform a genetic comparative analysis for the purpose of understanding
human evolution. Classically, comparative molecular studies have compared genetic
sequence or expression variation across species. However, recent work has compared
DNAm variation across species (Zeng et al., 2012; Hernando-Herraez et al., 2013), with
the hypothesis that species differences are due in part to gene regulatory differences
created by species-specific promoter methylation. In contrast, we explore here a trait
thought to be undergirded by epigenetic malleability and conserved across species.
A speculative interpretation of this data is that, in light of the strong conservation
of PTSD-associated CpG sites, the potential to epigenetically regulate responses to
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extreme traumatic stress may well be adaptive. Depending on environmental
circumstances, PTSD or anxiety states more generally, can increase or decrease
evolutionary fitness. Increased states of anxiety, although perhaps not ideal in many
situations, can theoretically increase evolutionary fitness (Nesse, 2001; 2005). For
example, genetic variants of catechol-O-methyltransferase (COMT) have been
associated with a tradeoff between cognitive ability and behavioral measures of anxiety
and stress resilience, giving rise to the so-called Worrier/Warrior selectionist model
(Stein et al., 2002; Goldman et al., 2005; Mier et al., 2010). An epigenetically regulated
developmental program that facilitates the plasticity required to assume an appropriate
phenotype in response to environmental conditions may be similarly adaptive(Meaney,
2010). Given that there is strong conservation of PTSD-associated CpG sites among
non-human primates, it may be the case that selective pressures have maintained the
capacity to increase or decrease PTSD-like responses to trauma, including reexperiencing-, avoidance-, emotional numbing-, social withdrawal-, and hyperarousaltype symptoms in response to lived experiences and environmental exposures. We
propose that the capacity to develop and epigenetically regulate a PTSD-like syndrome
is potentially present in many mammalian species. Indeed, symptoms resembling PTSD
and other mood disorders have been observed in chimpanzees (Bradshaw et al., 2008;
Ferdowsian et al., 2011). We do not, however, expect that all species will respond to
trauma exposure in the same way. Just as only a subset of trauma exposed humans
develop PTSD symptoms, it is likely that individual variation within and among species
is common in response to trauma exposure. Finally, the evolutionary history of the
capacity to epigenetically regulate trauma responsivity is significant in light of the finding
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that environmentally induced epigenetic inheritance interacts with lifetime stress to alter
brain development and genome activity (Crews et al., 2012).
Our study is limited by the number of CpG dinucleotides assessed by the
methylation microarray and the number of publically available genomes utilized. While
inclusion of additional genomes would have allowed the inference of phylogenetic
histories with greater resolution, doing so would have limited the number of CpG sites
analyzed in downstream analyses due to a larger number failing to meet our
requirement of an unambiguous multiple sequence alignment. Inclusion of more species
will provide valuable information and warrants further research. Indeed, because a large
number of PTSD-associated CpG sites are shared among primates, the replication of
this study with a more detailed primate phylogeny would be insightful. Additionally,
characterization of the evolutionary history of the human capacity to epigenetically
regulate trauma responses is limited by the incompleteness of PTSD-associated CpG
sites assessed. Specifically, only 203 of 624 PTSD-associated CpG sites from Uddin et
al (Uddin et al., 2010) were both alignable and perfectly parsimonious, and therefore
characterized here. That a majority of PTSD-associated CpG sites were unalignable or
perfectly parsimonious is evidence of the dynamic nature of CpG evolution. Future
studies are also needed to address the results here with regard to rapid deamination of
methylated cytosines. Because of the high deamination mutation rate of methylated
cytosines to thymines, there is an underrepresentation of CpG dinucleotides in the
human genome. This may largely explain the observation that the vast majority of CpG
evolution, including that of PTSD-associated CpGs, occurred more recently during
human descent. Given this, it may be reasonable to examine the functional significance
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of those PTSD-associated CpG sites that evolved more anciently, assuming that they
have been conserved because of a strong selection pressure to maintain them. The
observation that immune system genes are enriched among the analyzed genes on
more recent branches of human evolution does not necessarily imply that immune
genes are not important in the evolution of nonhuman lineages. Finally, it should be
noted that the identification of the PTSD-associated CpG sites analyzed here was
performed using DNA methylation obtained from peripheral blood samples. While brainderived DNA methylation data would be ideal to identify PTSD-associated biological
markers, this is not feasible given a desire to use samples provided by living humans.
However, individuals with PTSD have been shown to have reduced hippocampal area
and hyperactivated amygdala relative to trauma exposed controls (reviewed in (Pitman
et al., 2012)). Moreover, recent work suggests that there can be concordance between
DNA methylation patterns in the blood and brain for stress-relevant genes (Klengel et
al., 2013).
Interestingly, while we have traced and characterized the evolutionary history of
PTSD-associated CpG sites, we also now have data on the evolution of non-PTSDassociated CpG sites. Comparing the branch-specific rates of evolution demonstrates
that the rate of evolution of PTSD-associated CpG sites seems to scale linearly with
human descent – suggesting that the evolutionary pattern observed, at least in terms of
evolutionary rate, is a function of CpG evolution generally.
The vast majority of people experience a potentially traumatic event at some
point in their lifetime, yet relatively few subsequently develop the diagnosable mental
disorder PTSD. Elucidating the molecular and evolutionary underpinnings of severe
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trauma responses, such as PTSD, are required for the prevention and treatment of the
disorder and for identifying factors involved in discrepancies in risk and resilience. Here,
we contribute to the ongoing study of epigenetic influences on PTSD etiology and
differential risk by having traced and characterized the evolution of genomic sites
associated with the development of PTSD. Our data suggest that PTSD-associated
CpG sites are found at highly predicted transcription factor binding sites, that the
majority of such sites are shared by all primates and that the overrepresentation of
PTSD-associated CpGs proximal to immune system-related genes may have
disproportionately evolved during our more recent evolutionary history. Taken together,
this data supports the hypothesis that the DNA sequences necessary for the epigenetic
potential to develop a range of phenotypes in response to trauma (e.g. PTSD or
resiliency) in humans have deep evolutionary origins and are widely conserved among
mammalian species. It will be exciting to discover whether these epigenetic signals
contributed to the evolution of human brain function and/or dysfunction.
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Chapter 4. Genetic roles of the HPA axis in PTSD etiology
Abstract
Posttraumatic stress disorder (PTSD) is characterized by variable risk and resiliency,
with a minority of individuals exposed to trauma subsequently developing diagnosable
PTSD. Genetic variation may undergird this variable risk. Dysregulation of the
hypothalamic-pituitary-adrenal (HPA) axis is commonly observed among individuals
with PTSD and may underlie the etiology or symptoms of PTSD. As such, genetic
variants of genes involved in the HPA axis constitute candidates for association with
PTSD risk. The association between PTSD and 411 SNPs covering 21 HPA axis genes
was tested using set-based association tests. We utilized genomic SNP data from a
subset of the Detroit Neighborhood Health Study (DNHS), constituting 778 (traumaexposed individuals 140 cases, 638 controls). Our analyses failed to provide evidence
in support of association between HPA axis SNPs and PTSD risk. Although eight SNPs
were nominally statistically significantly associated with PTSD, none passed correction
for multiple hypothesis testing. Set-based tests were employed to test the significance
of sets of HPA axis SNPs, by gene, however no evidence of association with PTSD was
found at the set level. This study represents preliminary data on the association
between PTSD risk and HPA axis genetic variation. Numerous study design issues may
account for the negative results of this study. We discuss these explanations and
provide recommendations for future studies.
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Introduction
Post Traumatic Stress Disorder (PTSD) is an important medical issue (Kessler,
2000; Druss et al., 2009). In the United States, lifetime prevalence is estimated to be
6.8% in the general population (Kessler and Wang, 2008) and 15-40% in inner city and
combat-veteran populations (Villagomez et al., 1995; Breslau et al., 2004; Horowitz et
al., 2005; Schwartz et al., 2005). PTSD is associated with numerous comorbidities,
including an increased risk of major depression (Breslau et al., 2000), substance
dependence (Breslau et al., 2003), reduced life course opportunities (Kessler, 2000),
and physical health problems (Farley and Patsalides, 2001; Simpson, 2002; Zayfert et
al., 2002) including incident cardiovascular disease (Kessler, 2000; Kubzansky et al.,
2007; Kubzansky and Koenen, 2009; Kubzansky et al., 2009). The total cost to the
nation is an estimated $3.8 billion annually (Kessler, 2000). By definition, PTSD
develops following exposure to a Potentially Traumatic Event (PTE) (Shalev, 2001),
witnessed or experienced by the individual; this PTE must involve the threat or actuality
of death, injury, or physical integrity; and must cause clinically significant distress or
impairment in the individual’s social interactions, capacity to work or other important
areas of functioning(APA, 2013). Although a majority (50-90%) (Kessler et al., 1995) of
Americans experience a PTE in their lifetime, only a minority develop PTSD (Kessler et
al., 1995; Breslau et al., 1998; Acierno et al., 2007). Environmental factors at both
individual and community levels, such as gender, race, educational attainment (Kulka
RA, 1990; Brewin et al., 2000; Koenen et al., 2002; DiGrande et al., 2008; Galea et al.,
2008; Kun et al., 2009), socioeconomic position (Kulka RA, 1990; Brewin et al., 2000;
Koenen et al., 2002; Breslau et al., 2004; Koenen, 2007; DiGrande et al., 2008; Galea
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et al., 2008; Kun et al., 2009), and growing up in a low-income neighborhood (Breslau et
al., 1991; Koenen, 2007) have been associated with increased risk of PTSD. Whereas
some of this increased risk may be accounted for by individuals’ increased exposure to
assaultive violence (Breslau et al., 1998; Breslau et al., 2004; Coulton et al., 2007;
Melzer-Lange et al., 2007; Reyes et al., 2008; Gillespie et al., 2009; Obasaju et al.,
2009) (the type of PTE with highest conditional risk of PTSD), genetic variables offer
plausible biologic mechanisms to explain variable PTSD risk. Indeed, biological factors
may account in part for variable PTSD risk (Galea et al., 2006). Risk factor models
supported by meta-analytic studies explain only approximately 30-35% of the variance
in PTSD (Yehuda, 2001).
As the primary neuroendocrine system controlling the mammalian stress
response (Tsigos and Chrousos, 2002), genes involved in the regulation of the HPA
axis offer strong candidates for loci involved in PTSD etiology. Perception of stressful
stimuli causes the hypothalamic paraventricular nucleus to release corticotrophinreleasing hormone (CRH) and arginine vasopression (AVP) into the median eminence
to synergistically trigger the secretion of adrenocorticotropic hormone (ACTH) by
binding, respectively, the anterior pituitary corticotroph receptors CRH-R1 and V1B.
ACTH in turn triggers the production and secretion of glucocorticoid stress hormones
(GCs) – chiefly cortisol – from the adrenal cortex by binding melanocortin type2
receptors (MC2R) (Amweg et al., 2011). This interaction is facilitated by MC2R
accessory protein (MRAP). By binding GC-receptors (NR3C1) expressed in tissues
throughout the body, GCs mediate both the effects and, via negative feedback to the
hypothalamus, the termination of the stress response. Also known as the “fight or flight”
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mechanism, the stress response is initially adaptive; it mobilizes energy, increases
vigilance and focus, facilitates memory formation, and depresses the immune response
(Charney, 2004). However, failure to terminate the signal leads to the stress response
becoming pathological.
Downstream effects of chronically elevated HPA axis activity can lead to
detrimental consequences, including immune suppression and hippocampal atrophy
(Pruessner et al., 2010; Golub et al., 2011). Particularly relevant here, stress hormones
are implicated in the over-consolidation of memory in PTSD (Yehuda, 2001;
Rasmusson et al., 2003; Claes, 2004; de Kloet et al., 2006), thus suggesting that
variation in HPA axis genes may mediate a highly stress reactive phenotype vulnerable
to HPA axis dysregulation in response to trauma and therefore to PTSD development
(Kalin and Shelton, 2003). Indeed, aberrant functioning of the stress response is a
characteristic of PTSD phenomenology, frequently marked by increased levels of CRH
in CSF and decreased levels of plasma cortisol (Bremner et al., 1997; Baker et al.,
1999; Martin et al., 2010). This observation, namely the disagreement between central
and peripheral indicators of HPA axis activity, has led to the prediction that endocrine
glands downstream of the hypothalamus are either downregulated, inhibited by GC
negative feedback, or insensitive to the increased activity of stress response systems in
the brain (Pace and Heim, 2011). At the level of the hypothalamus, GC sensitivity varies
positively with GC and GC receptor concentration, and negatively with FKBP5
concentration. FKBP5 is a co-chaperone of the NR3C1 heterocomplex that regulates
hormone binding affinity and translocation of the NR3C1 heterocomplex to the nucleus
via an intracellular negative feedback loop. Several studies using dexamethasone
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suppression tests (Heim et al., 2008; Yehuda et al., 2009) and measurements within
circulating immune cells (de Kloet et al., 2007; Rohleder et al., 2010) have supported
the hypothesis that PTSD patients may exhibit enhanced GC-sensitivity. At the level of
the pituitary, decreased sensitivity may be due to either decreased concentration of
CRH, decreased expression of CRH receptors, and/or increased concentrations of
CRH-binding protein (CRH-BP). CRH-BP concentration is negatively correlated with
HPA-axis activity due to its ability to bind and inactivate free CRH. Furthermore, studies
have provided evidence that early life stress interacts with FKBP5 SNPs (Binder et al.,
2008) and CRH haplotype (Bradley et al., 2008) to modify risk of PTSD and depression,
respectively. Finally, at the level of the adrenal cortex, responsivity to the stress signal is
proportional to expression of melanocortin receptor type 2 (MC2R; receptor of ACTH)
and MC2R accessory protein (MRAP). MRAP regulates trafficking and function of
MC2R. As such, mutations of MRAP cause glucocorticoid deficiency (type 2).
It is well appreciated that PTSD risk is determined in part by genetic factors
(Slater and Slater, 1944; Radant et al., 2001; Segman et al., 2005; Koenen, 2007;
Koenen et al., 2008). Twin studies demonstrate that there is greater concordance of risk
in monozygotic vs. dizygotic twins (True et al., 1993; Stein et al., 2002; Koenen et al.,
2003), that PTSD is approximately 30% heritable (True et al., 1993; Stein et al., 2002),
and that children of PTSD-affected parents are more likely to develop PTSD (True et al.,
1993; Stein et al., 2002). Two studies have provided evidence for PTSD-related geneby-environment interactions at four SNPs at the FKBP5 locus (Binder et al., 2008; Xie et
al., 2010). Studying an almost exclusively low-income African-American sample, Binder
et al. provided evidence for an interaction between four FKBP5 SNPs and child abuse,
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such that genotype and early life trauma is predictive of PTSD symptom severity in later
life (Binder et al., 2008). Likewise, Xie et al. provided evidence of a gene-byenvironment interaction between a FKBP5 SNP and childhood adversity on PTSD risk
(Xie et al., 2010). This interaction was not significant for European-Americans (Xie et
al., 2010), suggesting putative ethnic/race-specific gene-by-environment effects.
Moreover, Bachmann et al. found that a negative correlation between basal cortisol
levels and PTSD severity existed in a subset of PTSD-affected combat veterans with a
specific genotype at a SNP at the NR3C1 locus (Bachmann et al., 2005). Finally, Lu et
al. identified correlations between four CNR1 SNPs and PTSD among white parents of
youth with attention hyperactivity disorder (Lu et al., 2008).
Based on the above discussions and additional evidence (e.g. (Newport et al.,
2003; Clark et al., 2008; de Kloet et al., 2008; Surget and Belzung, 2008; Carpenter et
al., 2009; Kellner et al., 2010)) we propose 21 HPA axis regulatory genes as
candidate genes for the study of association with PTSD risk (Table 7). Here, we
examined the association of PTSD with individual SNPs as well as sets of SNPs,
defined by gene.

Table 7. PTSD candidate genes, by level of HPA axis regulatory activity
Hypothalamus
AVP
AVPR1A
AVPR1B
CRH

CRHR1
CRHR2
LEP
LEPR

MC4R CRH
POMC CRHBP
UCN2 CRHR1
UCN3

Pituitary
CRHR2 POU1F1
FKBP5 PROP1
NR3C1 TBX19

Adrenal
Cortex
MC2R
MRAP

Periphery
UCN2
UCN3
NR3C1

NR3C2
CRHR1
CRHR2
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Materials and Methods
Sample Selection
The sample includes genotype data from a 778 individual subset of the Detroit
Neighborhood Health Study (DNHS), an epidemiological, community-representative
cohort of adult residents in Detroit, Michigan. The current study draws on survey data
and genotype data derived from DNA isolated from peripheral blood samples. Among
the samples, 140 have a history of PTSD and 638 have no history of PTSD. PTSD
diagnosis was assessed via structured interview administered via telephone (Breslau et
al., 1998). Lifetime PTSD cases met all six DSM-IV criteria in reference to either the
worst or random traumatic event. The diagnostic interview showed good validity against
the Clinician Administered PTSD Scale (Blake et al., 1995) as described elsewhere
(Uddin et al., 2010). The Institutional Review Board of the University of Michigan
reviewed and approved the study protocol. All individuals in this study had a history of
trauma exposure. Thus, comparisons reported are between trauma-exposed individuals
with and without PTSD. Participant demographic and PTSD status data is detailed in
Table 8.

Genotype data
Genotype data were obtained for the 778 participants at approximately 733,000
loci using the HumanOmniExpress platform (Illumina). Annotation of the genotype data
comes from the HumanOmniExpress_12v1_H dataset (Illumina), which utilized human
genome build hg19. Imputed data was not utilized. Sequenced DNA was isolated from
whole blood obtained via venipuncture from all study participants.
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Candidate gene selection
21 genes (Table 7) involved in the regulation and signaling of the HPA axis were
selected on the basis of evidence of involvement in the HPA axis as determined from a
literature search and use of the gene network database, Pharmacogenomics
Knowledge Base (PharmcoGKB) (Whirl-Carrillo et al., 2012) (Figure 8). The genes
represent a diverse range of functions within the HPA axis, including hormones,
hormone receptors, chaperones, targets and initiators of signaling. Using annotation
data for the genotyping beadchip supplied by Illumina (HumanOmniExpress_12v1_H),
411 SNPs were identified that were annotated to the 21 HPA axis candidate genes. A
breakdown of these SNPs, including SNP ID, refseq gene name, genomic coordinates,
and in which part of the gene each SNP lies (e.g. intron, exon, promoter region), can be
found in Supplemental Table S1.

Figure 8. HPA axis candidate gene activity within the HPA axis (left panel) and the
periphery (right panel). Figures used with permission from PharmaGKB (Whirl-Carrillo
et al., 2012) and Stanford University. Copyright to PharmGKB.
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Linkage disequilibrium, haplotype blocks, and tagging SNPs
For SNPs included in the study, Haploview (Broad Institute) (Barrett et al., 2005)
was used to estimate linkage disequilibrium and identify haplotype blocks and tagging
SNPs using population genetic data from the HapMap Project. Data representing
Yoruba from Ibadan, Nigeria (YRI) was utilized. Haploview was employed using default
settings.

Association tests
Association was tested between PTSD status and SNP genotype using a selfcontained set-test, employed in PLINK. We tested for associations between PTSD
status and individual SNPs as well as between PTSD status and sets of SNPs. Sets of
SNPs tested were defined by gene. Detailed lists of each set tested can be found in
Supplemental Table S2. A significance value of p<0.05 was utilized, with correction for
multiple hypothesis testing being completed using a Bonferroni correction.
A secondary analysis was completed by which gene sets were parsed by genic
context. Sets were parsed into a promoter/first exon set and a non-promoter/non-first
exon set. Promoter regions were defined as 1kb 5’ to the transcriptional start site.
Results
PTSD cases and controls differed with regard to age and gender (Table 8).
PTSD cases have significantly higher post-trauma symptom severity than do controls
(Table 8).
Table 8. Demographic and pre-trauma characteristics of 140 PTSD cases and 638
trauma-exposed controls.
PTSD (N=140)

Control
(N=638)

Chi-square
(df)

p-value
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Age (years)
Female
Post-trauma symptom severity

Mean/#
51.1
94
57.41

se/%
1.18
67%
1.17

Mean/#
54.6
353
28.10

se/%
0.67
55%
0.62

2.28 (776)
3.90(1)
20.46 (776)

0.023
0.048
<0.0001

HPA axis SNPs are not associated with PTSD risk
411 HPA axis SNPs were tested individually for association with PTSD status
between trauma-exposed individuals with and without PTSD. 8 SNPs were nominally
significant (Table 9), but did not withstand correction for multiple hypothesis testing.

Table 9. HPA axis SNPs nominally significantly associated with PTSD risk
Genomic
Affected
Unaffected
Gene
SNP
CHISQ
P
Coordinates Frequency Frequency
0.040
0.080
5.505 0.01897
LEPR
rs17415296 1:66099013
0.207
0.151
5.469 0.01936
FKBP5 rs16878806 6:35569119
4:149164905
0.022
0.056
5.428 0.01981
NR3C2 rs17484063
0.182
0.134
4.419 0.03553
NR3C2 rs17024437 4:149081808
0.072
0.114
4.211 0.04016
NR3C2 rs11099681 4:149103454
18:13911628
0.300
0.243
3.953 0.04680
MC2R rs877128
7:127895216
0.179
0.233
3.891 0.04855
LEP
rs17151922
0.096
0.141
3.878 0.04893
NR3C1 rs6861962 5:142750301

OR
0.4744
1.4750
0.3799
1.4440
0.6036
1.3350
0.7166
0.6528

Because no individual SNPs demonstrated a significant association with PTSD
following correction for multiple hypothesis testing, set-based tests were employed to
test for the significance of sets of SNPs. Neither a set composed of all HPA axis SNPs,
nor individual gene based sets were significantly associated with PTSD risk (Table 10).
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Table 10. HPA axis set-based association tests with PTSD risk.
NSNP
NSIG
ISIG
EMP1 SNPS
SET
AVP
3
0
0
1 NA
AVPR1A
8
0
0
1 NA
AVPR1B
13
0
0
1 NA
CRH
4
0
0
1 NA
CRHBP
8
0
0
1 NA
CRHR1
12
0
0
1 NA
CRHR2
9
0
0
1 NA
FKBP5
15
1
1 0.1379 rs16878806
LEP
18
1
1 0.5222 rs17151922
LEPR
57
1
1
0.317 rs17415296
MC2R
14
1
1
0.367 rs877128
MC4R
5
0
0
1 NA
MRAP
12
0
0
1 NA
NR3C1
97
1
1 0.6962 rs6861962
NR3C2
99
3
3 0.7594 rs17484063|rs17024437|rs11099681
POMC
5
0
0
1 NA
POU1F1
2
0
0
1 NA
PROP1
5
0
0
1 NA
TBX19
16
0
0
1 NA
UCN2
2
0
0
1 NA
UCN3
7
0
0
1 NA
NSNP, number of SNPs in gene-based set; NSIG, number of SNPs from set that are nominally
significantly associated with PTSD risk; ISIG, number of SNPs from set that are nominally
significantly associated with PTSD risk correcting for linkage disequilibrium-based
independence; EMP1, empirically significance value; SNPS, identificantion of independent (no
evidence of genetic linkage) SNPs from gene-based set that are nominally significantly
associated with PTSD risk.

Three NR3C2 SNPs were nominally significant for association with PTSD (Table
10). Linkage disequilibrium between any or all of these SNPs may affect any set-based
association tests which include them. Linkage disequilibrium analysis was thus
employed to rule out this potential confounder. rs17024437 (chr4:149,081,808) and
rs11099681 (chr4:149,103,454) are separated by approximately 20kb and thus were
considered candidates for being affected by genetic linkage. However, upon
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investigation, no evidence of linkage disequilibrium between these loci was found
(Figure 9).

Figure 9. No linkage disequilibrium between NR3C2 SNPs rs17024437
(chr4:149,081,808) and rs11099681 (chr4:149,103,454). rs11099681 is located in the
red box to the right of the figure. rs17024437 was not included in the Haploview
population data; it’s relative genomic location is marked in the figure above by a boxed
in star to the left of the figure. Figure created in Haploview 4.2, from the Broad Institute
(Barrett et al., 2005).

Because evidence suggests that DNAm is associated with gene expression in
ways that are contingent upon the context within which the CpG site of methylation is
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located, because DNAm is highly associated with PTSD risk, and because DNAm
patterns can be influenced by proximal genetic variation, we conducted a secondary
analysis to explore whether genetic context influenced SNP association with PTSD risk.
SNP sets were still defined by gene, but were parsed into separate “Promoter/First
Exon” and “Non-Promoter/Non-First Exon” sets. Despite this, no additional significant
findings resulted. The “Promoter/First Exon” sets contained no significant individual
SNPs and no significant sets. The “Non-Promoter/Non-First Exon” sets contained no
significant sets, including no substantial improvements upon non-parsed sets.

Discussion
Our data represents preliminary evidence that fails to support an association
between genetic variation within HPA axis genes and risk for or resiliency to PTSD
following exposure to trauma. Although eight SNPs were nominally significantly
associated with PTSD, none withstood corrections for multiple hypothesis testing.
Additionally, set-based tests that theoretically can demonstrate significance of sets even
when the SNPs that compose them are not individually significant also failed to
demonstrate significant associations with PTSD. While it is possible that there is indeed
no association between PTSD risk and the SNPs tested, there are many reasons why
this study design may have failed to detect a relationship between HPA axis genetic
variation and PTSD risk, including: the effects of gender, trauma history, and childhood
adversity; gene set selection that does not capture genetic diversity or fails to represent
biologically significant processes.
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Female gender (Kessler et al., 1995; Brewin et al., 2000; Tolin and Foa, 2006),
increased trauma history (Kessler et al., 1995), and the presence of childhood adversity
(Yehuda et al., 2010) are each associated with increased risk of PTSD. The primary
analyses reported here did not include these potentially important covariates. Future
work using this dataset may benefit from inclusion of these variables.
Composition of genes within sets would likely affect results of set-based tests,
even if using identical data. The set-based tests employed here use data from multiple
SNPs to estimate a set-based p-value. While the inclusion of more SNPs in this study
increased the probability of identifying highly significant SNPs, doing so may have
decreased the effective significance of any given set tested. The negative results from
this study may be taken as evidence that more biologically nuanced sets should be
tested. For example, limiting sets to SNPs found in regulatory regions or from genes
directly involved in regulation may improve the power of these set-based tests. Indeed,
many prior findings of significance between HPA axis genetic and epigenetic variants
and PTSD risk have included those genes that have direct regulatory roles (e.g. FKBP5
and NR3C1).
A more nuanced definition of PTSD may be helpful in identifying effects of HPA
axis gene variants. In this study we tested for the association between SNPs and PTSD
risk, with PTSD risk defined as any history of PTSD. As PTSD diagnostic criteria is
composed of three distinct categories of symptoms (hyperarousal, avoidance, and
intrusive memories), it may be helpful to analyze the association between HPA axis
genetic variants and individual symptoms types, separately. Indeed, it may make
biological sense that dysregulation the HPA axis may be more associated with
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symptoms of hyperarousal than of either of the other two symptom categories because
of the general alignment between this category and the classically-understood fight or
flight response. Another way in which PTSD definition may affect our results is the
decision to analyze PTSD as a dichotomous outcome. Post-trauma symptom severity is
a continuous measure of PTSD that has been alternatively utilized in the literature.
Employment of this measure may give additional power to the association analyses,
although an alternative method to set-based association tests would have to be
employed.
Finally, one speculative interpretation of this data is that failure to achieve
statistical significance may indicate a general conflation of chronic stress and acute
stress. The HPA axis functions to regulate the stress response. As such, allostatic
changes in the sensitivity of the system may be more increased following extended
periods of stress and trauma opposed to a single traumatic event. It is possible that
genetic variants affect the plasticity of the trauma response in such a way that a gene
by environment effect may be at the heart of the association between the HPA axis and
PTSD risk. In this way, certain genetic variants may be more susceptible to acute
stress, but more resilient to chronic stress (or vice versa). Analyzing all cases of PTSD
together, regardless of how chronic trauma is and number of traumatic exposures (e.g.
inclusion of childhood adversity history) and ignoring other aspects of stress, may have
prevented the elucidation of significant PTSD-HPA axis associations.
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Chapter 5. Discussion
Outlook
In this project I have undertaken studies designed to elucidate the proximate and
evolutionary underpinnings of PTSD, with an emphasis on the capacity for epigenetic
regulation. I have utilized Tinbergen’s Four Questions (Figure 2 from Chapter 1) guide
the design of the research that makes up this dissertation, with the aim to provide
proximate and evolutionary insights into the capacity to develop PTSD. In Chapter 2, I
reported evidence that the risk of PTSD is associated with pre-trauma epigenetic
variation and post-trauma epigenetic change at DNA methyltransferase genes in a
study that examined DNA methylation change longitudinally in trauma exposed
individuals with and without PTSD. That study shed light on the complex role of
epigenetics on PTSD etiology and thus contributes to answering Tinbergen’s Question
#2: What is the ontogeny? In Chapter 3, I reported evidence for the deep evolutionary
origins of PTSD epigenetic potential. That study demonstrated that the majority of
genetic CpG sites associated with epigenetic regulation of PTSD (at which differential
DNA methylation is associated with PTSD risk) are not unique to humans, but evolved
prior to the divergence of humans and chimpanzees, with many having considerably
more ancient origins. In that study I also characterized distinct periods of evolution
throughout human descent by calculating evolutionary rates and identifying enriched
functional annotation clusters of PTSD-associated CpG dinucleotide sites Chapter 3,
therefore, contributes to answering Tinbergen’s Question #4: What is the phylogeny?
Finally, in Chapter 4, I reported preliminary data that failed to support involvement of
genetic variation of HPA axis genes in differential risk and resiliency of PTSD. Despite
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negative results, I noted in that chapter various reasons why they may not reflect the
absence of a genetic involvement of HPA axis variation in PTSD risk and provided
recommendations for future studies. Thus, Chapter 4 contributes to answering
Tinbergen’s Question #3: What is the mechanism? These three projects may seem to
be conceptually very diverse, but in fact provide varying perspectives on the same
process, that of epigenetic regulation of PTSD. In sum, I have presented evidence that it
is important to look outside of genetics to identify biological risk factors for PTSD
(Chapters 4, 2), that epigenetic variation is associated with PTSD risk in complex and
dynamic ways both before and after trauma exposure (Chapter 2), and that the capacity
to epigenetically regulate PTSD has deep evolutionary origins with functional
implications (Chapter 3). These studies combine to paint a picture of PTSD as being
mediated by an epigenetically-regulated developmental process the capacity for which
is ancient and conserved. There are various ways in which this empirical evidence could
be understood and synthesized. Here, I approach PTSD as the extreme end of a
trauma response reaction norm that is the product of a capacity for developmental
plasticity that is evolutionarily conserved and mediated by ongoing epigenetic
modifications that respond to environmental stimuli. As such, this discussion will
synthesize the research detailed in Chapters 2-4 in order to contribute to the answer to
Tinbergen’s Question #4: What is the adaptation? Understanding how this perspective
is novel first requires a survey of the biological perspectives of PTSD that currently
predominate.

85

PTSD’s epistemic issues
Although important work has been done on the genealogy of the biological
understanding of trauma(Young, 1995) and the ways in which this understanding
structures nosology, research, and policy (Kendler KS, 2012), the epistemology of
PTSD is often ignored by biologists working in fields related to traumatic stress studies.
Instead, a common epistemological narrative has emerged both popularly and within the
scientific literature that understands PTSD to be both wound and disorder. This is
unique among mental health conditions defined by the DSM, as all other DSM
codifications are understood to be disorders. The acceptance of PTSD as both disorder
and wound is understandable given the lack of empirical data to resolve the nature of
PTSD and a need for a simple model upon which biological hypotheses can be built and
tested, but doing so may prevent the advancement of a more complete biological theory
of PTSD, as it precludes thinking about PTSD as a potentially adaptive trait, presumes
disorder and wound to be necessarily separate entities, and reduces PTSD etiology to a
simple interaction that can be localized in space and time. Our interpretations of
empirical data are shaped and constrained by the epistemology we accept and while
demystifying the biological nature of PTSD at one turn, the acceptance of this narrative
of PTSD potentially remystifies the problem anew at the next.
My intention here is not to resolve the question of the fundamental nature of
PTSD. As stated earlier, there is not at present enough empirical data to resolve even
the most basic of problems regarding whether PTSD is wound, disorder, both, or
something else entirely. What I would like to propose, however, is that thinking about
PTSD as an adaptive and evolutionarily conserved trait that is regulated by epigenetic
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potential allows for a novel interpretation of PTSD molecular data that spans ontological
scales from individual development to phylogenetic evolution and that has practical
implications for both research and clinical practice.

PTSD as wound and disorder
What is the basic understanding of PTSD and how does it structure our
understanding of empirical data? Diagnostically, PTSD is composed of two fundamental
elements – exposure to a traumatic event and the subsequent development of posttrauma symptoms (hyperarousal, intrusive memories, and avoidance) (APA, 1994;
Association, 2013). Criterion A of DSM-IV PTSD diagnostic criteria requires “exposure
to a traumatic event in which the person (1) experienced, witnessed, or was confronted
by death or serious injury to self or others AND (2) responded with intense fear,
helplessness, or horror” (APA, 1994). As such, Criterion A establishes PTSD as a
wound such that the condition of having PTSD is contingent upon first having an
experience that exists outside of one’s own biology. PTSD is caused, therefore, by
something external. It should be noted that PTSD is unique among DSM
psychopathologies in requiring a precipitating event (APA, 1994; Lopez-Ibor, 2002;
Association, 2013). The upshot is that PTSD is understood to be a wound, roughly
analogous to that caused by a gunshot (for example, see (Committee on the
Assessment of Ongoing Effects in the Treatment of Posttraumatic Stress and Institute
of, 2012).
But a gunshot injures all individuals in roughly the same way, whereas traumatic
experiences affect people in dramatically different ways. Although a majority of
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Americans experience a potentially traumatic event in their lifetime (Norris, 1992;
Resnick et al., 1993; Kessler et al., 1995; Breslau et al., 1998), only a minority
subsequently develop PTSD (Kessler et al., 1995; Breslau et al., 1998; Acierno et al.,
2007). Additionally, those who experience even those traumatic events which carry the
highest conditional risk for PTSD (among civilians, the conditional risk of PTSD
following rape is 65% in males and 46% in females (Kessler et al., 1995)) are not
guaranteed to develop PTSD. The development of PTSD, therefore, remains rare
despite the high frequency of traumatic experiences. Is PTSD, then, more correctly
seen as a disorder, analogous to all of the other psychopathologies codified within the
DSM?
The disorder model understands PTSD to be the result of something gone wrong
within an individual as a susceptibility only to be revealed upon exposure to a traumatic
experience. As mentioned above, all other mental health diagnoses roughly take this
form. Although we may point to environmental factors that influence the etiology of
depression, schizophrenia, and autism, to name just a few, these conditions are
ultimately understood to be caused by something innately different between those who
suffer from them and those who do not. Hypotheses about the disordered nature of
PTSD predict the ability to locate the disorder that confers PTSD risk in everything from
culturally-determined psychology, such as perceived discrimination and religious
involvement (Scrimin et al., 2014), to brain form and function (Li et al., 2014), to genetic
variants (Guffanti et al., 2013; Logue et al., 2013; Solovieff et al., 2014).
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Combining these models of PTSD we arrive at the typical understanding of PTSD
today – PTSD is the result of the interaction between a trauma induced wound and a
preexisting, risk-conferring disorder.
In the remainder of this chapter I will start by describing this general conception
of PTSD – as depicted by the diathesis-stress model. I will describe the ways in which a
focus on epigenetics has changed the thinking about PTSD in such a way as to
biologically unify the “wounds” of traumatic experience and risk-conferring “disorder.” I
will relate how this has given rise to a more nuanced life course model of PTSD.
Drawing from the developmental origins of health and disease literature, I will then
propose an alternative model of PTSD – as a phenotypic range within a trauma
response reaction norm that arises out of an epigenetically-regulated developmental
plasticity that is conserved through evolutionary history. Having described this
perspective, I will contrast it with other evolutionary perspectives on PTSD and attempt
to incorporate into this model my own research, as described in detail in Chapters 2-4,
to demonstrate how this model can incorporate thinking about PTSD on multiple levels.
Finally, I will provide a brief synopsis on how this perspective may influence research,
clinical practice, and policy.

From diathesis-stress to an epigenetic life course model
The diathesis stress model of PTSD argues that differential risk of PTSD is the result of
the interaction between external trauma (stress) and pre-existing susceptibility factors
(diathesis) (Yehuda et al., 2011; Mehta and Binder, 2012). This model has informed
much of the important research on PTSD in recent years and has primarily led to the
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attempt to identify risk and resiliency factors as biological correlates of the psychiatric
symptoms of PTSD. Specifically, this research has led to the identification of numerous
biological risk factors as well as gene by environment interactions that are associated
with PTSD risk. For example, studying an almost exclusively low-income AfricanAmerican sample, Binder and colleagues provided evidence for an interaction between
four FKBP5 SNPs and child abuse, such that genotype and early life trauma was found
to be predictive of PTSD symptom severity in later life (Binder et al., 2008); Xie and
colleagues also provided evidence of a gene-by-environment interaction between a
FKBP5 SNP and childhood adversity, although this interaction was not significant for
European-Americans (Xie et al., 2010). Bachmann and colleagues reported a negative
correlation between basal cortisol levels and PTSD severity in a subset of PTSDaffected combat veterans with a specific NR3C1 SNP genotype (Bachmann et al.,
2005). And Lu and colleagues identified correlations between four CNR1 SNPs and
PTSD among white parents of youth with attention hyperactivity disorder(Lu et al.,
2008). Within the realm of neuroanatomy, morphological abnormalities have been linked
to PTSD in various forms, including a volumetric reduction in cerebral gray matter and
hippocampal volume (Li et al., 2014), and functional and connective differences in
numerous central nervous system regions, including: the amygdala, insula, and
prefrontal lobe (Jin et al., 2013).
While much of this research has centered on identifying genetic and
neuroanatomical risk factors and the interaction between these risk factors and
environmental trauma exposure, evidence of involvement of epigenetics

has

revolutionized the research program by providing a putative mechanism to unite stress
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and diathesis (Meaney, 2010). In short, because epigenetic factors are stable yet
modifiable in response to lived experience, they potentially can function as both disorder
and wound, as both diathesis and stress.
Indeed, recent work in the field of epigenetic psychiatry has identified epigenetic
modifications that affect an individual’s response to trauma and others that are induced
by trauma. The first indication of this role of epigenetic variation came from the
foundational work by Michael Meaney and colleagues who demonstrated that
epigenetic modifications are capable of being induced by early life experiences and
persisting into adulthood to modify behavior and physiology. Most famously, rat pups
that received high levels of maternal care during early postnatal life, as measured by the
amount of received licking and grooming and arched-back nursing, as adults displayed
more mild physiological responses to stress and higher maternal care behaviors
themselves compared to pups that received low levels of maternal care (Weaver et al.,
2004). These effects were found to be mediated by an epigenetic modification, induced
by exposure to early childhood to licking, grooming and arched-back nursing, of the
gene that codes for the glucocorticoid receptor Nuclear Receptor Subfamily 3, Group C,
Member 1 (NR3C1). Pups who received high degrees of maternal care had reduced
levels of hippocampal DNA methylation and increased gene expression of NR3C1
glucocorticoid receptor (Weaver et al., 2004). Importantly, NR3C1 is a modulator of the
stress response and an integral component of the hypothalamic-pituitary-adrenal (HPA)
axis. Indeed, these epigenetic changes were found to be concordant with differences in
adult HPA axis responses to stressful stimuli, as measured by circulating corticosterone
following restraint stress. This research demonstrated that lived experiences could lead
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to epigenetic modifications capable of modulating behavior and biology and stable
through time. Follow up work built on these findings by identifying similar epigenetic
effects in other genes, including BDNF (Roth et al., 2009) and estrogen receptoralpha1b (Champagne et al., 2006). Further research has yielded yet more evidence of
the role of epigenetics in mental health, generally, and PTSD, specifically, by expanding
this foundational work into humans.
As in mice, stress and trauma experienced early in life has epigenetic effects that
last into adulthood in humans. Among suicide victims, increased NR3C1 methylation
was observed in the brains of suicide victims with a history of childhood abuse,
compared to suicide victims without a history of childhood abuse. The association
between increased DNA methylation at NR3C1 loci and early life exposures to stress
and trauma has been demonstrated in additional studies. Increased methylation of a
NGFI-A binding site at a NR3C1 locus while in cord blood was found to be associated
with maternal mood, with more active stress responses measured via salivary cortisol at
3 months postnatally (Oberlander et al., 2008). Additionally, increased NR3C1 DNA
methylation was observed in whole blood samples from individuals with a history of
childhood adversity (Tyrka et al., 2012). In addition to focused candidate gene studies,
epigenetic differences associated with exposure to early life stress have been identified
– Compared with adolescents whose mothers were unexposed to high stress levels
during their first year of life, adolescents whose mothers reported high stress levels
during their infancy showed higher DNAm levels at 139 CpG sites in buccal cell-derived
DNA (Essex et al., 2013). Together, these data from animal and human studies suggest
that early life experiences, and especially adverse early life experiences, have the
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potential to alter epigenetic gene regulation and downstream gene function with lasting
physiological, behavioural, and psychological implications (Meaney, 2010; Szyf, 2011).
By constituting both disorder and wound, epigenetic variation and modifications
provides a core around which a coherent life course approach to PTSD can be
constructed. A, perhaps oversimplified, description of such an approach, emphasizing
the role of epigenetics, would locate both risk factors that pre-exist trauma (“disorders”)
and trauma-induced risk factors (“wound”) in epigenetic variation. Doing so collapses
false dichotomies of diathesis vs. stress, nature vs. nurture, gene vs. environment, and
biology vs. society/culture on to the mediating effects of epigenetics; the effect of each
seemingly disparate input affects the output of mental health via epigenetic states and
modifications. In this way, an individual at greater risk of PTSD is “disordered” because
of certain epigenetic variation and is “wounded” by trauma by the induction of further
epigenetic variation, all of which leads to more global effects physiology and behavior
via changes in gene expression and transcription factor binding.
Additionally, a life course approach creates a more nuanced understanding of the
role of environmental trauma exposures on the etiology of PTSD. Despite diagnostic
criteria (APA, 1994), research (Hong et al., 2014), and treatment (e.g. exposure
therapy) that often centers on a single traumatic experience as the precipitating event of
subsequent PTSD development, it is clear that the biological reality of PTSD is more
complex; the etiology of PTSD is influenced by the entirety of lived experience. Indeed,
evidence suggests that the number of traumatic experiences interacts with genetic
variation to affect risk of PTSD (Koenen et al., 2011; Uddin et al., 2011a), risk of PTSD
increases with each traumatic experience, and one of the greatest risk factors for the
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development of adult PTSD is childhood adversity even when childhood adversity does
not itself induce PTSD (LeardMann et al., 2010). Furthermore, many individuals develop
PTSD following several traumatic event exposures, with symptoms that don’t track
cleanly onto any single experience (Cloitre et al., 2009). Finally, numerous social factors
exist that increase the risk of PTSD, independent of any association with increased
exposure to traumatic exposure, including: perceived discrimination, lower religious
involvement, and less social support (Scrimin et al., 2014). These observations are
putatively explained using this life course approach by the induction of epigenetic
modifications of lived experiences that, in turn, increase the risk of PTSD in response to
future traumatic exposures.
An epigenetic life course approach to PTSD considers the ongoing interaction
between phenotype and environment, as opposed to a single interaction (Uddin and
Sipahi, 2013). As such, PTSD as a phenotype arises out of a series of epigeneticallymediated phenotype-by-environment interactions (Figure 10; (Uddin and Sipahi, 2013)).

94

Figure 10. A life course model of PTSD. (A) The etiology of posttraumatic stress
disorder (PTSD) is contingent upon a series of developmental responses, mediated by
epigenetic modifications, to lifetime social experiences. Two potential scenarios are
illustrated in panels B and C. (B) Adverse childhood and adult experiences compound to
increase risk of mental illness. Arrows represent epigenetically mediated developmental
responses to social exposures. (C) Absence of childhood adversity allows for resiliency
in the face of traumatic experiences in adulthood. In the social exposure (SE) columns,
background color gradient represents developmental plasticity, with darker background
indicating greater developmental plasticity and thus likely greater influence over future
health. G, underlying inherited genotype.
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It is important to note that while both my description here and the accompanying
figure each present the etiology of PTSD as arising out of a series of distinct events or
timeframes, it is perhaps more accurate to consider PTSD as the product of a long
developmental process that may be marked by events of greater or lesser significance,
but as a whole is neither disjointed nor discrete. We can envision, for example, that
experiences of everyday racism and sexism, chronic stress over a lack or loss of life
course opportunities, and trouble integrating within stable social networks, to name but
a few contributing factors, each are translated into increased risk of PTSD via subtle,
ongoing epigenetic modifications.
Indeed, the research presented in Chapter 3 supports a life course approach to
PTSD. In that study, risk-associated biological differences were observed in the form of
pre-trauma epigenetic risk factors and post-trauma DNA methylation modifications.
Importantly, we observed some changes in DNA methylation from pre- to post-trauma
time points that were unique to individuals who developed PTSD and others which were
shared by cases and controls alike (Sipahi et al., 2014). This suggests that trauma
induces epigenetic changes in a predictable way regardless of whether PTSD
subsequently develops. This may represent an empirical example of the type of events
displayed in Figure 10. While that research controlled for the number of trauma
exposure types, future research that took prior traumatic experiences into account in
more nuanced ways may provide insight into the etiology of PTSD as the product of a
lifelong developmental process. Additionally, while it is possible that the pre-trauma
epigenetic risk factors identified in Chapter 3 may have been inherited or otherwise
independent of lived experience, this observation is also consistent with the prediction
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that these are the products of previous lived experiences, previous epigenetically
regulated phenotype by environment interactions. Finally, while we only studied a
limited number of loci – 15 total CpG dinucleotide sites over 4 DNMT genes – we
predict that similar dynamic effects are at play at other epigenetic loci. Uddin and
colleagues previously identified over 600 differentially methylated CpG sites across the
genome in association with PTSD risk (Uddin et al., 2010). How many of these are
dynamically regulated in response to traumatic experiences, how many occupy
biologically relevant roles and thus confer risk or resiliency, and how many are reliable
biomarkers of PTSD risk or state are questions that remain to be elucidated via future
research, but that may be informed by a life course approach.

Developmental plasticity and developmental origins of health and disease
We have seen that stressful and traumatic life experiences are translated into
biological consequences by epigenetic modifications. That this happens predictably and
in ways that in turn modulate future responses to stressful and traumatic experiences in
a form that approximates a norm of reaction suggests that these changes may be
functional. It is difficult, yet important, to distinguish between 1) the phenotypic results of
a developmental program that is passively shaped by environmental inputs and 2) the
phenotypic results of a developmental program that actively and functionally responds
to environment inputs. This is a subtle difference, but one that carries tremendous
implications for understanding PTSD and thus worth teasing apart. The distinction
essentially can be reduced to whether a given example of phenotypic plasticity is
adaptive or nonadaptive. In the case of PTSD, if we take for granted that the biological
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trauma response is plastic in response to lived traumatic exposures, the question
becomes whether this represents an active or passive form of plasticity.
A clear articulation of this distinction comes from the examination of the effect of
mechanical forces on the developing organism by Moore (Moore, 2003), who has
identified four functions of the mechanical environment on the developing organism: 1)
the mechanical environment can alter development via the inherent developmental
plasticity of the organism; 2) the mechanical environment can provide information used
by the developmental process itself; 3) the mechanical environment can provide a
selection pressure; and 4) the mechanical environment can be itself changed by the
developing organism. Items (3) and (4) relate to broader evolutionary questions, so I will
focus, for the time being, on (1) and (2), which correspond to the numbered distinctions
on the previous page. Function (1), passive plasticity, can be seen in many examples:
enzymatic responses to pH and temperature changes (Pavasovic et al., 2004),
decreased growth rate in response to low nutrient availability (Larque et al., 2013), and
growth shape of coral molded by wave forces (Dollar, 1982). In contrast, classic
examples of scenario (2), active plasticity, include plasticity that results in distinct
polyphenisms, such as solitary and gregarious locust phenotypes (Applebaum and
Heifetz, 1999), heterophylly in semiaquatic plants (Wells and Pigliucci, 2000), and
morphology, reproductive strategy, and behavior of horned beetles (Valena and
Moczek, 2012), to name but a few. Although most easily understood as plasticity that is
responsible for polyphenic traits, active plasticity can also result in less distinct
phenotypic forms that approximate norms of reactions, such as the development of the
adaptive immune system (Galli et al., 2011). In addition, more complex syndromes,
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composed of expansive complements of traits, have been predicted to represent the
result of an adaptive form of phenotypic plasticity – for example, the thrifty phenotype
and thrifty epigenotype theories of metabolic syndrome (Hales and Barker, 1992;
Bateson and Gluckman, 2011). From this perspective, metabolic syndrome is the result
of a plastic developmental process that responds to cues from the environment. Low
nutrient availability in utero is hypothesized to initiate a developmental trajectory,
mediated by epigenetic modifications, towards a thriftier phenotype (Barker et al., 1989;
Waterland and Michels, 2007; Wadhwa et al., 2009). Such a phenotype is thought to be
evolutionarily advantageous if the in utero cues accurately represent and predict the
future environmental reality – namely, nutrient availability.
Can we conceive of a similar process leading to the etiology of PTSD? Similar to
metabolic disorder, PTSD is characterized by phenotypic plasticity in response to
environmental cues – past trauma may predict future trauma (Tyler and Johnson, 2006;
Klest, 2012). Also, similar to metabolic syndrome, PTSD seems to be a disorder in so
far as the phenotype does not appropriately match the environment. However, in
contrast to metabolic disorder, which is defined in relation to a largely stable
environment (in the western world, high nutrient availability is a fairly consistent reality),
PTSD is defined in relation to a much more unstable environment.
It is illustrative to consider when PTSD becomes a disorder. If we hypothesize
that the symptoms of PTSD (hyperarousal, avoidance, emotional numbing, and intrusive
memories) are effective in leading to decreased exposure to future traumatic events,
then it becomes clear that there are no clear delimiting boundaries for disease onset.
Take for instance, a soldier who develops PTSD following exposure to combat. Is PTSD
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a disorder if it prevents her from future exposure to life-threatening trauma? Is it a
disorder as soon as she leaves the combat zone and returns to the relative safety of
home? If she is then redeployed does her PTSD again cease to be a disorder? The
case of a military veteran with multiple deployments may be an extreme example of
dynamic environmental change, but it is also true for many civilians who face changing
interpersonal relationships and a more difficult time escaping from the types of
situations that may relate to past traumatic exposures.
It is difficult to know when tradeoffs such as developmental plasticity are
evolutionarily adaptive. Likewise, it is unclear if the capacity to develop symptoms of
PTSD in the face of trauma is adaptive. But, by combining the life course model of
PTSD etiology described earlier with the proximate ontological evidence from Chapter 2
and the phylogenetic evidence from Chapter 3, it becomes plausible that the capacity to
develop PTSD via active plasticity is adaptive.

An evolutionary perspective
Interest in the relationship between evolution and epigenetics has recently seen
a resurgence, although it is not a new field.

Theoreticians are revisiting and

reinterpreting work by Waddington, Baldwin, and others in order to elucidate the role
epigenetics can play in driving evolution (West-Eberhard, 2003; Pigliucci, 2010). The
relationship between evolution and epigenetics is bidirectional – epigenetics influences
and, perhaps, drives evolution and evolution shapes epigenetic processes (Baldwin,
1896; 1897; Badyaev, 2009; Feinberg and Irizarry, 2010). My own research has focused
on the latter of this relationship.
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Evolutionary theories about PTSD tend to occupy three camps. In the first, PTSD
is seen to be the result of normal biological processes gone awry. The stress-diathesis
model, when considering evolution, largely falls into this camp. In addition to the basic
premises of the stress-diathesis model, the language utilized is revealing of its
evolutionary theoretical underpinnings; as a representative example, (Ehlert, 2013)
refers to certain responses to traumatic experiences, including PTSD, as “severe
maladjustment with co-occurring psychiatric and physical pathologies.”. In the second,
PTSD is seen as an unfortunate evolutionary trade-off;

for example, the biological

sensitivity to context theory hypothesizes that individuals who are more susceptible to
negative health effects following adversity (e.g. increased risk of PTSD) also have more
potential to benefit from positive conditions (Boyce and Ellis, 2005; Ellis et al., 2011). As
such, this theory hypothesizes that the development of PTSD in response to trauma is
evolutionarily disadvantageous, but the very neurodevelopmental processes increase
fitness in more “positive” social conditions. Finally, in the third, PTSD is seen as a
mismatch between phenotype and environment such that the development of PTSD in
response to traumas may have once been evolutionarily advantageous, but not longer
makes sense (Silove, 1998)

Implications for research, clinical practice, and policy
What is most restricting about the prevailing model of PTSD is the assumption of
negativity. Wounds are bad and disorders are bad, necessarily, and the assumption of
negativity precludes thinking about PTSD as adaptive or beneficial in any way. The
stress-diathesis model attempts to be valueless, yet what constitutes stress is largely
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informed by assumptions that arise primarily from cultural norms. Our theories about
PTSD,

specifically,

and

mental

health,

generally,

tend

to

conflate

cultural

understandings of ordered vs. disordered thinking, biological understandings of function
and dysfunction, and evolutionary understandings of adaptation and maladaptation. We
take for granted that PTSD is a disorder and a wound at all levels, from molecular to
evolutionary to societal. Theories of PTSD that are informed by an evolutionary
perspective tend to recognize the need to differentiate between cultural norms,
biological dysfunction, and mismatches between phenotype and environment. In this
way they are improvements upon theories that ignore evolutionary insights. However, at
their core, they still operate on the assumption that PTSD is “bad”. Perhaps this is true.
I in no way mean to suggest that PTSD is somehow a preferable state, nor that it
shouldn’t be treated. PTSD is real and it is a medical and social issue. However, I would
like to suggest that PTSD is neither disorder nor wound, in that PTSD represents the
product of a functional developmental program that responds to lived traumatic
experiences. The upshot of this perspective is that the responsibility of PTSD falls upon
a society that creates the conditions for trauma, in the first instance. If PTSD arises in
individuals that are responding appropriately, in an evolutionary sense, to traumatic
exposures, then it becomes difficult to rationalize the focus of treatment, prevention, and
policy being placed on individuals with PTSD. There are few examples of targeting a
functional system for medical treatment. As an analogy, although we medically treat a
fever if it is life threatening, we recognize that a fever is an evolved, adaptive response
to infection. As such, we tend not to treat a fever, per se, but focus our intention on the
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actual cause of medical concern. The infection is the real problem and, appropriately,
we focus our efforts to prevent, treat, and limit the spread of the infectious agent.
We ought to take a similar approach with PTSD. While understanding that PTSD
is rooted in biology, treatment and prevention of PTSD may best be accomplished by
pursuing policy and social reforms designed to reduce the etiological agent of PTSD,
which ultimately is trauma itself.
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APPENDIX
Supplemental Table 1. All evolved PTSD-associated CpG dinucleotides (7202)
Name
cg06648029
cg10125195
cg13397379
cg17108383
cg18809535
cg24172553
cg27303882
cg27318281
cg27412902
cg01091565
cg01558777
cg01770400
cg06084117

Symbol
NR1I2
LACRT
OR2C3
PCDHGC5
LDHAL6B
FLJ25660
PAGE2
C18orf37
IL29
MESP1
C10orf99
SERPINC1
PLXNA4B

cg06445611
cg08256781
cg09950370
cg10134939
cg11204562
cg12177001
cg18129786
cg18330203
cg18790143
cg20732137
cg21695020
cg23654219
cg24505375
cg25729716
cg02044879
cg03570766
cg04587829
cg05244766
cg10498097
cg11148307
cg18271969
cg21596858
cg00962459
cg02629257

GeneID
8856
90070
81472
56097
92483
148109
203569
125476
282618
55897
387695
462
91584

Accession
NM_022002.1
NM_033277.1
NM_198074.3
NM_018929.2
NM_033195.1
NM_152481.1
NM_207339.1
NM_194281.2
NM_172140.1
NM_018670.1
NM_207373.1
NM_000488.2
NM_181775.2

node_change
node_13_human
node_13_human
node_13_human
node_13_human
node_13_human
node_13_human
node_13_human
node_13_human
node_13_human
node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13

PTSD-association
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected

GABRR2
ACSBG2

2570
81616

NM_002043.1
NM_030924.2

node_14_node_13
node_14_node_13

Uniquely Methylated, Affected
Uniquely Methylated, Affected

GFRA2
FLJ13391

2675
84141

NM_001495.4
NM_032181.1

node_14_node_13
node_14_node_13

Uniquely Methylated, Affected
Uniquely Methylated, Affected

C10orf81
IFI27
ZNF445
TNNT2
OTOS
GMEB2

79949
3429
353274
7139
150677
26205

NM_024889.3
NM_005532.3
NM_181489.4
NM_000364.2
NM_148961.3
NM_012384.2

node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13

Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected

DPEP3
TCF19
AMAC1L2
CD79B
PLA2G12B
CATSPER1
FN3K
GSTP1
MGC50811
C10orf92
HTR3C
DCST2
PROKR1
EPPB9

64180
6941
83650
974
84647
117144
64122
2950
375307
54777
170572
127579
10887
27077

NM_022357.1
NM_007109.1
NM_054028.1
NM_000626.1
NM_032562.2
NM_053054.2
NM_022158.2
NM_000852.2
NM_198559.1
NM_017609.2
NM_130770.2
NM_144622.1
NM_138964.2
NM_015681.2

node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14

Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
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cg02854090
cg08025786
cg09174741
cg16242770
cg18034859
cg18992201
cg24751129
cg25833031

HIST1H2AA
CLK3
THSD1
KRTAP17-1
MYLK2
DPPA2
GNMT
PAPD1

221613
1198
55901
83902
85366
151871
27232
55149

NM_170745.3
NM_003992.1
NM_018676.2
NM_031964.1
NM_033118.2
NM_138815.2
NM_018960.4
NM_018109.2

node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14

Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected

cg26687173
cg27077685

cg04033774
cg05958352

LOC126248
SLC7A6OS
CYTL1
C9orf132
AXUD1
IL11RA
TIMM13
MIP
GPSM2
RNASE1

126248
84138
54360
399665
64651
3590
26517
4284
29899
6035

NM_173479.2
NM_032178.1
NM_018659.2
NM_203305.1
NM_033027.2
NM_004512.3
NM_012458.2
NM_012064.2
NM_013296.3
NM_198232.1

node_15_node_14
node_15_node_14
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15

Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected

cg06308323
cg07443748
cg07531356
cg09923671
cg13288195
cg14845091

C9orf25
CESK1
INSL6
GATA5
FBXL22
ADPRHL1

203259
150160
11172
140628
283807
113622

NM_147202.1
NM_014406.4
NM_007179.2
NT_011362.9
NM_203373.1
NM_199162.1

node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15

Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected

cg17754680
cg17894008
cg19233472
cg19812619
cg20074593
cg20668607
cg20972495
cg22194129
cg24024214
cg24073022

NPC1L1
NACAL
FOXI1
ITGB7
GPR17
DNAJC11
SEC22L3
CLEC4C
BTNL8
TAL2

29881
342538
2299
3695
2840
55735
9117
170482
79908
6887

NM_013389.1
NM_199290.2
NM_012188.3
NM_000889.1
NM_005291.1
NM_018198.1
NM_032970.2
NM_130441.2
NM_024850.1
NM_005421.1

node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15

Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected

cg24661752
cg24734575
cg24867501
cg25762706
cg26220985
cg27182551
cg07711515
cg16772207
cg12439773

AP2M1
SLC7A9
MIOX
STMN4
DPT
RB1
BAG1
MYT1
SLC22A6

1173
11136
55586
81551
1805
5925
573
4661
9356

NM_004068.3
NM_014270.3
NM_017584.5
NM_030795.2
NM_001937.3
NT_024524.13
NM_004323.3
NM_004535.2
NM_004790.3

node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_21_node_20
node_21_node_20
node_22_node_21

Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected
Uniquely Methylated, Affected

cg00512031
cg02009694
cg02254461
cg03662459
cg03870261
cg03986640

105
cg02838492
cg02774160
cg23106779
cg01344518
cg05654164
cg07196761
cg10618882
cg14959707

KIF12
GGT1
CXorf2
RGS11
C1orf52
WDR71
LRRC25
ZC3H7A

113220
2678
1527
8786
148423
80227
126364
29066

NM_138424.1
NM_005265.2
NM_001586.1
NM_183337.1
NM_198077.1
NM_025155.1
NM_145256.2
NM_014153.2

node_23_node_22
node_13_human
node_13_human
node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13

Uniquely Methylated, Affected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected

cg16087263
cg16879596

cg14784348
cg18598959

PLA2G2F
CYP3A5
CCND1
SDCBP2
GDPD2
SLC39A5
SERPINA10
C1orf111
HCFC1
PIK4CB

64600
1577
595
27111
54857
283375
51156
284680
3054
5298

NM_022819.2
NM_000777.2
NT_078088.3
NM_015685.3
NM_017711.2
NM_173596.1
NM_016186.1
NM_182581.1
NM_005334.1
NM_002651.1

node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14

Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected

cg20828084
cg03003745
cg13316424
cg20399252
cg20437604
cg21142272

KIAA1199
UNQ473
CIZ1
EBPL
ANXA9
LOC283849

57214
284340
25792
84650
8416
283849

NM_018689.1
NM_198477.1
NM_012127.2
NM_032565.1
NM_003568.1
NM_178516.2

node_15_node_14
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15

Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected

cg23431988
cg14818279
cg25677709
cg08341924
cg01443452
cg11098259
cg22956254
cg01155039
cg01623438
cg08123074

PIWIL2
SH3TC2
NDST1
TGM1
GAPDHS
AQP9
GDF3
AMN
CTSZ
PHACTR4

55124
79628
3340
7051
26330
366
9573
81693
1522
65979

NM_018068.2
NM_024577.2
NM_001543.3
NM_000359.1
NM_014364.3
NM_020980.2
NM_020634.1
NM_030943.1
NM_001336.2
NM_023923.2

node_17_node_15
node_20_node_17
node_21_node_20
node_22_node_21
node_23_node_22
node_13_human
node_13_human
node_14_node_13
node_14_node_13
node_14_node_13

Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Methylated, Unaffected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected

cg11952714
cg16296356
cg19531130
cg20938359
cg21406461
cg22933847
cg27365426
cg05091653
cg06933965

SNX7
RAD51L3
ANGPTL5
SLC6A12
IFI16
MRGPRF
ARHGAP15
SP100
CMKLR1

51375
5892
253935
6539
3428
219928
55843
6672
1240

NM_015976.2
NM_002878.2
NM_178127.2
NM_003044.2
NM_005531.1
NM_145015.2
NM_018460.2
NM_003113.2
NM_004072.1

node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13
node_14_node_13
node_15_node_14
node_15_node_14

Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected

cg19047670
cg24950749
cg25685838
cg03343942
cg05788638
cg14701962
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cg08090640
cg09503974
cg09735598
cg14165663
cg17749456
cg00540769
cg01813965
cg07612655

IFI35
RARRES1
RGL1
GALR2
HSPBP1
ACOT12
C16orf50
PTGIS

3430
5918
23179
8811
23640
134526
84229
5740

NM_005533.2
NM_002888.2
NM_015149.2
NM_003857.2
NM_012267.2
NM_130767.1
NM_032269.3
NM_000961.3

node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14

Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected

cg13406950
cg13471990

cg03017653
cg05163348

GBP1
ENTPD1
LST1
SULT1C2
IL8
TBC1D21
RASSF5
HM13
TTC13
RPP30

2633
953
7940
27233
3576
161514
83593
81502
79573
10556

NM_002053.1
NM_001776.3
NM_205838.1
NM_006588.2
NM_000584.2
NM_153356.1
NT_021877.18
NM_178580.1
NM_024525.2
NM_006413.2

node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15

Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected

cg05829479
cg06196379
cg06306751
cg06495347
cg08475827
cg09076077

C6orf141
TREM1
F8
SUOX
RIF1
FLJ33860

135398
54210
2157
6821
55183
284756

NM_153344.1
NM_018643.2
NM_000132.2
NM_000456.2
NM_018151.3
NM_173644.1

node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15

Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected

cg09580336
cg10213821
cg10521852
cg11299964
cg11368643
cg12127282
cg12697789
cg15239579
cg17173423
cg19342782

ATP1A1
G10
EDG4
MAPKAP1
PCDHB15
HOXD4
TLR3
TRAP1
MS4A3
ANKRD13C

NM_000701.6
NM_003910.2
NM_004720.4
NM_001006620.1
NM_018935.2
NM_014621.2
NM_003265.2
NM_016292.1
NM_006138.4
NM_030816.2

node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15

Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected

cg20318748
cg21042619
cg21092324
cg22764341
cg23398173
cg23591853
cg26815229
cg08899626
cg24673765

NANP
EED
MMRN1
ATP10D
MTPN
IFT172
CYP2J2
LDB2
HSPB6

NM_152667.1
NM_003797.2
NM_007351.2
NM_020453.2
NM_145808.1
NM_015662.1
NM_000775.2
NM_001290.2
NM_144617.1

node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_21_node_20
node_21_node_20

Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected
Uniquely Unmethylated, Affected

cg14324675
cg17966192
cg18302652
cg00427635
cg01860753
cg02151301

476
8896
9170
79109
56121
3233
7098
10131
932
81573
140838
8726
22915
57205
136319
26160
1573
9079
126393

107
cg25293251
cg02806777
cg07455279
cg17421623
cg01079126
cg11320084
cg19535609
cg24127874

GOLGA5
PGLYRP1
NDUFA3
C3orf9
MTMR1
RNF2
B3GNT4
HES6

cg00186701
cg11325578

cg08532057
cg12335708

TSPYL5
GPR143
MAOA
AFAP
PRAF2
ZNF540
KRTAP13-2
ARTN
NUPL1
DPP4

cg14132995
cg15768203
cg16227684
cg17552650
cg17860158
cg17963840

9950
8993
4696
56983
8776
6045
79369
55502

NM_005113.2
NM_005091.1
NM_004542.1
NM_152305.1
NM_003828.1
NM_007212.3
NM_030765.2
NM_018645.3

node_13_human
node_14_node_13
node_14_node_13
node_14_node_13
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14

Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected

85453
4935
4128
60312
11230
163255
337959
9048
9818
1803

NM_033512.2
NM_000273.1
NM_000240.2
NM_198595.1
NM_007213.1
NM_152606.2
NM_181621.2
NM_003976.2
NM_014089.3
NM_001935.3

node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_15_node_14
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15

Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected

SLC35A2
PPIG
GDI1
WDR45
CNTN2
ADRA1A

7355
9360
2664
11152
6900
148

NM_005660.1
NM_004792.2
NM_001493.1
NM_007075.3
NM_005076.2
NM_033302.1

node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15

Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected

cg18486150
cg18910313
cg19118077
cg20507276
cg20622056
cg20825323
cg22598563
cg23066860
cg25713185
cg20792833

KIF17
P2RY11
AKR1C3
OR2L13
SLC7A3
IGBP1
P4HA2
GPRASP2
SLC19A3
PTPRCAP

57576
5032
8644
284521
84889
3476
8974
114928
80704
5790

NM_020816.1
NM_002566.4
NM_003739.4
NM_175911.2
NM_032803.3
NM_001551.2
NM_004199.2
NM_138437.3
NM_025243.2
NM_005608.2

node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_17_node_15
node_21_node_20

Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected

cg10709021
cg14473924
cg21835643

WRN
PDZRN3
RBPSUHL

7486
23024
11317

NM_000553.2
NM_015009.1
NM_014276.2

node_22_node_21
node_22_node_21
node_22_node_21

Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected
Uniquely Unmethylated, Unaffected

cg19441691
cg19564367
cg20371650
cg27389185
cg02493771
cg06207804
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Posttraumatic stress disorder (PTSD) is an important medical and social
condition. Although the vast majority of individuals are exposed to traumatic events
within their lifetime, a minority subsequently develop diagnosable PTSD.

What

underlies differential risk and resiliency in the face of trauma is an ongoing research and
clinical question with implications for prevention and treatment. Recent work has
revealed a putative role of epigenetic variation and modification – most notably DNA
methylation – in the etiology of PTSD. That DNA methylation is stable, yet modifiable in
response to lived experiences, makes it a strong candidate to mechanistically explain
the ontogeny of PTSD by putatively linking genetic and environment effects. Here, I
provide proximate and evolutionary insights into this biological capacity through three
distinct, but conceptually related research projects. In the first, I compare DNA
methylation longitudinally in trauma-exposed individuals with and without PTSD to
reveal a complex role of epigenetic variation and modification in PTSD development. In
the second, I utilize phylogenetic methods to infer and characterize the evolutionary
history of genetic loci necessary for the epigenetic regulation of PTSD, revealing that
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this capacity may have ancient origins. In the third, I test, and fail to provide evidence
for, genetic associations between PTSD risk and single nucleotide polymorphisms
(SNPs) annotated to genes involved in the regulation and activity of the hypothalamicpituitary-adrenal (HPA) axis. Taken together, these data are suggestive of an
evolutionarily-conserved capacity to regulate behavior, physiology, and psychology in
response to extreme traumatic experiences. I argue that this capacity is epigenetically
regulated and represents an example of adaptive developmental phenotypic plasticity.
This model of PTSD etiology has implications for policy, clinical practice, public health,
and research.
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